Document:

EX-4.2

 Exhibit 4.2 
 SUPPLEMENTAL INDENTURE NO. 7 
 by and between 

HEALTH CARE REIT, INC. 
 and 
 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. 

As of December 6, 2012 
 SUPPLEMENTAL TO THE INDENTURE DATED AS OF MARCH 15, 2010 
  

 
 HEALTH CARE
REIT, INC. 
 2.250% Senior Notes due 2018 
 3.750% Senior Notes due 2023 
 5.125% Senior Notes due 2043 

 This SUPPLEMENTAL INDENTURE NO. 7 (this “Supplemental Indenture”) is made and
entered into as of December 6, 2012 between HEALTH CARE REIT, INC., a Delaware corporation (the “Company”), and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association duly organized and existing under the laws
of the United States of America, as Trustee (the “Trustee”). 
 WITNESSETH THAT: 

WHEREAS, the Company and the Trustee have executed and delivered an Indenture, dated as of March 15, 2010 (as amended, supplemented
or otherwise modified from time to time, the “Base Indenture” and, together with this Supplemental Indenture, as amended, supplemented or otherwise modified from time to time, the “Indenture”) to provide for the future issuance
of the Company’s senior debt securities (the “Securities”) to be issued from time to time in one or more series; and 
 WHEREAS, pursuant to the terms of the Base Indenture, the Company desires to provide for the establishment of each of three new series of its Securities, to be known respectively as its 2.250% Senior
Notes due 2018, its 3.750% Senior Notes due 2023 and its 5.125% Senior Notes due 2043, the form and substance of such Securities and the terms, provisions and conditions thereof to be set forth as provided in the Indenture. 

NOW, THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH: 
 ARTICLE 1 
 DEFINED TERMS 

Section 1.1 The following definitions supplement, and, to the extent inconsistent with, replace the definitions in
Section 101 of the Base Indenture: 
 “Business Day” means any day other than a Saturday or Sunday or a day on
which banking institutions in the City of New York are required or authorized to close. 
 “Capital Lease” means at
any time any lease of property, real or personal, which, in accordance with GAAP, would at such time be required to be capitalized on a balance sheet of the lessee. 
 “Capitalized Lease Obligations” means, as to any Person, the obligations of such Person to pay rent or other amounts under a lease of (or other agreement conveying the right to use) real and/or
personal property which obligations are required to be classified and accounted for as a Capital Lease on a balance sheet of such Person under GAAP. 
 “Cash” means as to any Person, such Person’s cash and cash equivalents, as defined in accordance with GAAP consistently applied. 

 “DTC” means The Depository Trust Company located at 55 Water Street, 1SL, New
York, New York, 10041-0099. 
 “EBITDA” means for any period, with respect to the Company and its subsidiaries on a
consolidated basis, determined in accordance with GAAP, the sum of net income (or net loss) for such period PLUS, the sum of all amounts treated as expenses for: (i) interest, (ii) depreciation, (iii) amortization and (iv) all
accrued taxes on or measured by income to the extent included in the determination of such net income (or net loss); provided, however, that net income (or net loss) shall be computed without giving effect to extraordinary losses or gains.

 “Funded Indebtedness” means as of any date of determination thereof, (i) all Indebtedness of any Person,
determined in accordance with GAAP, which by its terms matures more than one year after the date of calculation, and any such Indebtedness maturing within one year from such date which is renewable or extendable at the option of the obligor to a
date more than one year from such date, and (ii) the current portion of all such Indebtedness. 
 “GAAP” means
generally accepted accounting principles. 
 “Global Notes” has the meaning specified in Section 2.1(a) of this
Supplemental Indenture. 
 “Indebtedness” means, with respect to any Person, all: (i) liabilities or obligations,
direct and contingent, which in accordance with GAAP would be included in determining total liabilities as shown on the liability side of a balance sheet of such Person at the date as of which Indebtedness is to be determined, including, without
limitation, contingent liabilities that in accordance with such principles, would be set forth in a specific dollar amount on the liability side of such balance sheet, and Capitalized Lease Obligations of such Person; (ii) liabilities or
obligations of others for which such Person is directly or indirectly liable, by way of guaranty (whether by direct guaranty, suretyship, discount, endorsement, take-or-pay agreement, agreement to purchase or advance or keep in funds or other
agreement having the effect of a guaranty) or otherwise; (iii) liabilities or obligations secured by Liens on any assets of such Person, whether or not such liabilities or obligations shall have been assumed by it; and (iv) liabilities or
obligations of such Person, direct or contingent, with respect to letters of credit issued for the account of such Person and bankers acceptances created for such Person. 
 “Interest Coverage” means as of the last day of any fiscal quarter, the quotient, expressed as a percentage (which may be in excess of 100%), determined by dividing EBITDA by Interest Expense;
all of the foregoing calculated by reference to the immediately preceding four fiscal quarters of the Company ending on such date of determination. 
 “Interest Expense” means for any period, on a combined basis, the sum of all interest paid or payable (excluding unamortized debt issuance costs) on all items of Indebtedness of the Company
outstanding at any time during such period. 
 “Interest Payment Date” with respect to the Notes is defined in
Section 101 of the Base Indenture and Section 2.1(b) of this Supplemental Indenture. 

  
 2 

 “Lien” means any mortgage, deed of trust, pledge, security interest, encumbrance,
lien, claim or charge of any kind (including any agreement to give any of the foregoing), any conditional sale or other title retention agreement, any lease in the nature of any of the foregoing, and the filing of or agreement to give any financing
statement under the Uniform Commercial Code of any jurisdiction. 
 “Make-Whole Amount” means, in connection with any
optional redemption or accelerated payment of any Notes, the excess, if any, of (i) the aggregate present value as of the date of such redemption or accelerated payment of each dollar of principal being redeemed or paid and the amount of
interest (exclusive of interest accrued to the date of redemption or accelerated payment) that would have been payable in respect of each such dollar if such redemption or accelerated payment had not been made, determined by discounting, on a
semi-annual basis, such principal and interest at the Reinvestment Rate (determined on the third Business Day preceding the date such notice of redemption is given or declaration of acceleration is made) from the respective dates on which such
principal and interest would have been payable if such redemption or accelerated payment had not been made, over (ii) the aggregate principal amount of the Notes being redeemed or paid. 

“Notes” means the Company’s 2.250% Senior Notes due 2018 (the “2018 Notes”), 3.750% Senior Notes due 2023 (the
“2023 Notes”) and 5.125% Senior Notes due 2043 (the “2043 Notes”) each issued under the Indenture as a separate series. For the purposes of this Supplemental Indenture, unless otherwise specified herein, references to the
“Notes” shall be deemed to refer to each series of Notes separately, and not to the 2018 Notes, the 2023 Notes and the 2043 Notes on any collective basis. 
 “Regular Record Date” with respect to the Notes is defined in Section 101 of the Base Indenture and Section 2.1(b) of this Supplemental Indenture. 

“Reinvestment Rate” means 0.25% in the case of the 2018 Notes, 0.30% in the case of the 2023 Notes and 0.35% in the case of the
2043 Notes, plus, in each case, the arithmetic mean of the yields under the respective heading “Week Ending” published in the most recent Statistical Release under the caption “Treasury Constant Maturities” for the maturity
(rounded to the nearest month) corresponding to the remaining life to maturity, as of the payment date of the principal being redeemed or paid. If no maturity exactly corresponds to such maturity, yields for the two published maturities most closely
corresponding to such maturity shall be calculated pursuant to the immediately preceding sentence and the Reinvestment Rate shall be interpolated or extrapolated from such yields on a straight-line basis, rounding in each of such relevant periods to
the nearest month. For the purpose of calculating the Reinvestment Rate, the most recent Statistical Release published prior to the date of determination of the Make-Whole Amount shall be used. 

“Senior Debt” means all Indebtedness other than Subordinated Debt. 

“Statistical Release” means that statistical release designated “H.15(519)” or any successor publication that is
published weekly by the Federal Reserve System and that 

  
 3 

 
establishes yields on actively traded United States government securities adjusted to constant maturities, or, if such statistical release is not published at the time of any determination under
the Indenture, then such other reasonably comparable index that shall be designated by the Company. 
 “Subordinated
Debt” means any unsecured Indebtedness of the Company which is issued or assumed pursuant to, or evidenced by, an indenture or other instrument which contains provisions for the subordination of such other Indebtedness (to which appropriate
reference shall be made in the instruments evidencing such other Indebtedness if not contained therein) to the Notes (and, at the option of the Company, if so provided, to other Indebtedness of the Company, either generally or as specifically
designated). 
 “Subsidiary” means any corporation or other entity of which a majority of (i) the voting power of
the voting equity securities or (ii) the outstanding equity interests of which are owned, directly or indirectly, by the Company or one or more other Subsidiaries of the Company. For the purposes of this definition, “voting equity
securities” means equity securities having voting power for the election of directors or similar functionaries, whether at all times or only so long as no senior class of security has such voting power by reason of any contingency. 

“Total Assets” means on any date, the consolidated total assets of the Company and its Subsidiaries, as such amount would
appear on a consolidated balance sheet of the Company prepared as of such date in accordance with GAAP. 
 “Total
Unencumbered Assets” means on any date, net real estate investments (valued on a book basis) of the Company and its Subsidiaries that are not subject to any Lien which secures indebtedness for borrowed money of any of the Company and its
Subsidiaries plus, without duplication, loan loss reserves relating thereto, accumulated depreciation thereon plus Cash, as all such amounts would appear on a consolidated balance sheet of the Company prepared as of such date in accordance with
GAAP; provided, however, that “Total Unencumbered Assets” does not include net real estate investments under unconsolidated joint ventures of the Company and its Subsidiaries. 

“Unsecured Debt” means Funded Indebtedness less Indebtedness secured by Liens on the property or assets of the Company and its
Subsidiaries. 
 ARTICLE 2 
 TERMS OF THE NOTES 
 Section 2.1 Pursuant to Section 301
of the Indenture, the Notes shall have the following terms and conditions: 
 (a) Title; Aggregate Principal Amount; Form of
Notes. The Notes shall be Registered Securities under the Indenture each as a separate series, and shall be known respectively as the Company’s “2.250% Senior Notes due 2018,” “3.750% Senior Notes due 2023” and
“5.125% Senior Notes due 2043.” The 2018 Notes will be limited to an aggregate principal amount of 

  
 4 

 
$450,000,000, the 2023 Notes will be limited to an aggregate principal amount of $500,000,000 and the 2043 Notes will be limited to an aggregate principal amount of $250,000,000. Each series
shall be subject to the right of the Company to reopen such series for issuances of additional securities of such series and except (i) as provided in this Section and (ii) for Securities authenticated and delivered upon registration of
transfer of, or in exchange for, or in lieu of, other Securities of the series pursuant to Section 304, 305, 306, 906 or 1107 of the Indenture and except for any Securities which, pursuant to Section 303 of the Indenture, are deemed never
to have been authenticated and delivered hereunder. The 2018 Notes (together with the Trustee’s certificate of authentication) shall be substantially in the form of Exhibit A hereto, the 2023 Notes (together with the Trustee’s
certificate of authentication) shall be substantially in the form of Exhibit B hereto and the 2043 Notes (together with the Trustee’s certificate of authentication) shall be substantially in the form of Exhibit C hereto, each of
which is hereby incorporated in and made a part of this Supplemental Indenture. 
 The Notes will be issued in the form of fully
registered global securities without coupons (“Global Notes”) that will be deposited with, or on behalf of, DTC, and registered in the name of DTC’s partnership nominee, Cede & Co. Except under the circumstance described
below, the Notes will not be issuable in definitive form. Unless and until it is exchanged in whole or in part for the individual notes represented thereby, a Global Note may not be transferred except as a whole by DTC to a nominee of DTC or by a
nominee of DTC to DTC or another nominee of DTC or by DTC or any nominee of DTC to a successor depositary or any nominee of such successor. 
 So long as DTC or its nominee is the registered owner of a Global Note, DTC or such nominee, as the case may be, will be considered the sole owner or holder of the Notes represented by such Global Note
for all purposes under this Supplemental Indenture. Except as described below, owners of beneficial interest in Notes evidenced by a Global Note will not be entitled to have any of the individual Notes represented by such Global Note registered in
their names, will not receive or be entitled to receive physical delivery of any such Notes in definitive form and will not be considered the owners or holders thereof under the Indenture or this Supplemental Indenture. 

If DTC is at any time unwilling, unable or ineligible to continue as depositary and a successor depositary is not appointed by the
Company within 90 days, the Company will issue individual Notes in exchange for the Global Note or Global Notes representing such Notes. In addition, the Company may at any time and in its sole discretion, subject to certain limitations set forth in
the Indenture, determine not to have any of such Notes represented by one or more Global Notes and, in such event, will issue individual Notes in exchange for the Global Note or Global Notes representing the Notes. Individual Notes so issued will be
issued in minimum denominations of $2,000 and integral multiples of $1,000. 
 (b) Interest and Interest Rate.

 (i) The 2018 Notes will bear interest at a rate of 2.250% per annum, from December 6, 2012 (or, in
the case of 2018 Notes issued upon the reopening of this series, from the date designated by the Company in connection with such reopening) or from the 

  
 5 

 
immediately preceding 2018 Notes Interest Payment Date to which interest has been paid or duly provided for, payable semiannually in arrears on each March 15 and September 15,
commencing September 15, 2013 (each of which shall be a “2018 Notes Interest Payment Date”), to the Persons in whose names the 2018 Notes are registered in the Security Register at the close of business on March 1 or
September 1, as the case may be (whether or not a Business Day), next preceding such 2018 Notes Interest Payment Date (each, a “2018 Notes Regular Record Date”). 

(ii) The 2023 Notes will bear interest at a rate of 3.750% per annum, from December 6, 2012 (or, in the case of
2023 Notes issued upon the reopening of this series, from the date designated by the Company in connection with such reopening) or from the immediately preceding 2023 Interest Payment Date to which interest has been paid or duly provided for,
payable semiannually in arrears on each March 15 and September 15, commencing September 15, 2013 (each of which shall be a “2023 Notes Interest Payment Date”), to the Persons in whose names the 2023 Notes are registered in
the Security Register at the close of business on March 1 or September 1, as the case may be (whether or not a Business Day), next preceding such 2023 Notes Interest Payment Date (each, a “2023 Notes Regular Record Date”).

 (iii) The 2043 Notes will bear interest at a rate of 5.125% per annum, from December 6, 2012 (or, in
the case of 2043 Notes issued upon the reopening of this series, from the date designated by the Company in connection with such reopening) or from the immediately preceding 2043 Notes Interest Payment Date to which interest has been paid or duly
provided for, payable semiannually in arrears on each March 15 and September 15, commencing September 15, 2013 (each of which shall be a “2043 Notes Interest Payment Date”), to the Persons in whose names the 2043 Notes are
registered in the Security Register at the close of business on March 1 or September 1, as the case may be (whether or not a Business Day), next preceding such 2043 Notes Interest Payment Date (each, a “2043 Notes Regular Record
Date”). 
 (iv) For purposes of this Supplemental Indenture and the Notes, references herein or therein to
(A) an “Interest Payment Date” shall be deemed to refer to the applicable 2018 Notes Interest Payment Date, 2023 Notes Interest Payment Date or 2043 Interest Payment Date, as the context so requires; and (B) a “Regular
Record Date” shall be deemed to refer to the applicable 2018 Notes Regular Record Date, 2023 Notes Regular Record Date or 2043 Notes Regular Record Date, as the context so requires. 

(c) Principal Repayment; Currency. The 2018 Notes will mature on March 15, 2018, the 2023 Notes will mature on March 15,
2023 and the 2043 Notes will mature on March 15, 2043; provided, however, the Notes may be earlier redeemed at the option of the Company as provided in paragraph (d) below. The principal of each Note payable on its maturity date shall be
paid against presentation and surrender thereof to Corporate Trust Operations of the Trustee, located at 111 Sanders Creek Parkway, East Syracuse, NY 13057, in such coin or currency of the United States of America as at the time of payment is legal
tender for the payment of public or private debts. 

  
 6 

 (d) Redemption at the Option of the Company. The Notes will be subject to redemption
at the option of the Company, at any time in whole or from time to time in part, upon not less than 30 nor more than 60 days’ notice to each Holder of Notes to be redeemed at its address appearing in the Security Register. If the Notes are
redeemed, the redemption price will equal the sum of (i) the principal amount of the Notes (or portion of such Notes) being redeemed, plus accrued and unpaid interest thereon to but excluding the applicable Redemption Date, and (ii) the
Make-Whole Amount, if any; provided, however, that if the 2023 Notes are redeemed 90 or fewer days prior to their maturity date, the redemption price will equal 100% of the principal amount of the 2023 Notes (or portion of such Notes)
being redeemed plus accrued and unpaid interest thereon to but excluding the Redemption Date; and provided further, however, that if the 2043 Notes are redeemed 180 or fewer days prior to their maturity date, the redemption price will
equal 100% of the principal amount of the 2043 Notes (or portion of such Notes) being redeemed plus accrued and unpaid interest thereon to but excluding the Redemption Date. 
 (e) Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted by facsimile. Notices to the Company shall be
directed to it at 4500 Dorr Street, Toledo, Ohio 43615, Attention: General Counsel; notices to the Trustee shall be directed to it at The Bank of New York Mellon Trust Company, N.A., 525 Vine St., Suite 900, Cincinnati, Ohio 45202, Attention:
Corporate Trust Administration, Re: Health Care REIT, Inc. 2.250% Senior Notes due 2018, 3.750% Senior Notes due 2023 and/or 5.125% Senior Notes due 2043 (as applicable); or as to either party, at such other address as shall be designated by such
party in a written notice to the other party. 
 (f) Global Note Legend. Each Global Note shall bear the following legend
on the face thereof: 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY,
A NEW YORK CORPORATION (“DTC”), TO ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED
REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 (g) Applicability of Discharge,
Defeasance and Covenant Defeasance Provisions. The Discharge, Defeasance and Covenant Defeasance provisions in Article Thirteen of the Indenture will apply to the Notes. 

  
 7 

 ARTICLE 3 
 ADDITIONAL COVENANTS 
 Section 3.1 Holders of the Notes shall
have the benefit of the following covenants, in addition to the covenants of the Company set forth in Articles Eight and Ten of the Indenture: 
 (a) The Company will not pledge or otherwise subject to any Lien, any property or assets of the Company or its Subsidiaries unless the Notes are secured by such pledge or Lien equally and ratably with all
other obligations secured thereby so long as such other obligations shall be so secured; provided, however, that such covenant shall not apply to the following: 
 (i) Liens securing obligations that do not in the aggregate at any one time outstanding exceed 40% of the sum of (A) the Total Assets of the Company and its consolidated subsidiaries as of the end of
the calendar year or quarter covered in the Company’s Annual Report on Form 10-K or Quarterly Report on Form 10-Q, as the case may be, most recently filed with the Commission (or, if such filing is not permitted under the Exchange Act, with the
Trustee) prior to the incurrence of such additional Liens and (B) the purchase price of any real estate assets or mortgages receivable acquired, and the amount of any securities offering proceeds received (to the extent that such proceeds were
not used to acquire real estate assets or mortgages receivable or used to reduce Indebtedness), by the Company or any Subsidiary since the end of such calendar quarter, including those proceeds obtained in connection with the incurrence of such
additional Liens; 
 (ii) Pledges or deposits by the Company or its Subsidiaries under workers’ compensation
laws, unemployment insurance laws, social security laws, or similar legislation, or good faith deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness of the Company or its Subsidiaries), or leases to which
the Company or any of its Subsidiaries is a party, or deposits to secure public or statutory obligations of the Company or its Subsidiaries or deposits of cash or United States Government Bonds to secure surety, appeal, performance or other similar
bonds to which the Company or any of its Subsidiaries is a party, or deposits as security for contested taxes or import duties or for the payment of rent; 
 (iii) Liens imposed by law, such as carriers’, warehousemen’s, materialmen’s and mechanics’ liens, or Liens arising out of judgments or awards against the Company or any of its
Subsidiaries which the Company or such Subsidiary at the time shall be currently prosecuting an appeal or proceeding for review; 
 (iv) Liens for taxes not yet subject to penalties for non-payment and Liens for taxes the payment of which is being contested in good faith and by appropriate proceedings; 

(v) Minor survey exceptions, minor encumbrances, easements or reservations of, or rights of, others for rights of way,
highways and railroad crossings, sewers, electric lines, telegraph and telephone lines and other similar purposes, or zoning or other restrictions as to the use of real properties; 

  
 8 

 (vi) Liens incidental to the conduct of the business of the Company or any
Subsidiary or to the ownership of their respective properties that were not incurred in connection with Indebtedness of the Company or such Subsidiary, all of which Liens referred to in this clause (vi) do not in the aggregate materially impair
the value of the properties to which they relate or materially impair their use in the operation of the business taken as a whole of the Company and its Subsidiaries, and as to all of the foregoing referenced in clauses (ii) through (vi), only
to the extent arising and continuing in the ordinary course of business; 
 (vii) Purchase money Liens on
property acquired or held by the Company or its Subsidiaries in the ordinary course of business, securing Indebtedness incurred or assumed for the purpose of financing all or any part of the cost of such property; provided, however, that
(A) any such Lien attaches concurrently with or within 20 days after the acquisition thereof, (B) such Lien attaches solely to the property so acquired in such transaction, (C) the principal amount of the Indebtedness secured thereby
does not exceed 100% of the cost of such property and (D) the aggregate amount of all such Indebtedness on a consolidated basis for the Company and its Subsidiaries shall not at any time exceed $1,000,000; 

(viii) Liens existing on the Company’s balance sheet as of December 31, 2001; and 

(ix) Any extension, renewal or replacement (or successive extensions, renewals or replacements), as a whole or in part, of
any Lien referred to in the foregoing clauses (ii) through (viii) inclusive; provided, however, that the amount of any and all obligations and Indebtedness secured thereby shall not exceed the amount thereof so secured immediately prior to
the time of such extension, renewal or replacement and that such extension, renewal or replacement shall be limited to all or a part of the property which secured the Lien so extended, renewed or replaced (plus improvements on such property).

 (b) The Company will not create, assume, incur, or otherwise become liable in respect of, any Indebtedness if the aggregate
outstanding principal amount of Indebtedness of the Company and its consolidated subsidiaries is, at the time of such creation, assumption or incurrence and after giving effect thereto and to any concurrent transactions, greater than 60% of the sum
of (i) the Total Assets of the Company and its consolidated subsidiaries as of the end of the calendar year or quarter covered in the Company’s Annual Report on Form 10-K or Quarterly Report on Form 10-Q, as the case may be, most recently
filed with the Commission (or, if such filing is not permitted under the Exchange Act, with the Trustee) prior to the incurrence of such additional Indebtedness and (ii) the purchase price of any real estate assets or mortgages receivable
acquired, and the amount of any securities offering proceeds received (to the extent that such proceeds were not used to acquire real estate assets or mortgages receivable or used to reduce Indebtedness), by the Company or any Subsidiary since the
end of such calendar quarter, including those proceeds obtained in connection with the incurrence of such additional Indebtedness. 

  
 9 

 (c) The Company will have or maintain, on a consolidated basis, as of the last day of each
of the Company’s fiscal quarters, Interest Coverage of not less than 150%. 
 (d) The Company will maintain, as of the last
day of each of the Company’s fiscal quarters and at all times, Total Unencumbered Assets of not less than 150% of the aggregate outstanding principal amount of the Unsecured Debt of the Company and its Subsidiaries on a consolidated basis.

 (e) For purposes of this Section 3, Indebtedness and Debt shall be deemed to be “incurred” by the Company or a
Subsidiary whenever the Company or such Subsidiary shall create, assume, guarantee or otherwise become liable in respect thereof. 
 ARTICLE 4 
 ADDITIONAL EVENTS OF DEFAULT 

Section 4.1 For purposes of this Supplemental Indenture and the Notes, in addition to the Events of Default set forth in
Section 501 of the Indenture, each of the following also shall constitute an “Event of Default:” 
 (a) default
in the payment of the principal of or any premium on the Notes at Maturity; 
 (b) there shall occur a default under any bond,
debenture, note or other evidence of indebtedness of the Company, or under any mortgage, indenture or other instrument of the Company (including a default with respect to Securities of any series other than that series) under which there may be
issued or by which there may be secured any indebtedness of the Company (or by any Subsidiary, the repayment of which the Company has guaranteed or for which the Company is directly responsible or liable as obligor or guarantor), whether such
indebtedness now exists or shall hereafter be created, which default shall constitute a failure to pay an aggregate principal amount exceeding $10,000,000 of such indebtedness when due and payable after the expiration of any applicable grace period
with respect thereto and shall have resulted in such indebtedness in an aggregate principal amount exceeding $10,000,000 becoming or being declared due and payable prior to the date on which it would otherwise have become due and payable, without
such indebtedness having been discharged, or such acceleration having been rescinded or annulled, within a period of 10 days after there shall have been given, by first class mail, to the Company by the Trustee or to the Company and the Trustee by
the Holders of at least a majority in principal amount of the Outstanding Notes a written notice specifying such default and requiring the Company to cause such indebtedness to be discharged or cause such acceleration to be rescinded or annulled and
stating that such notice is a “Notice of Default” under the Indenture; and 
 (c) the entry by a court of competent
jurisdiction of one or more judgments, orders or decrees against the Company or any of its Subsidiaries in an aggregate amount (excluding 

  
 10 

 
amounts covered by insurance) in excess of $10,000,000 and such judgments, orders or decrees remain undischarged, unstayed and unsatisfied in an aggregate amount (excluding amounts covered by
insurance) in excess of $10,000,000 for a period of 30 consecutive days. 
 Section 4.2 Notwithstanding any
provisions to the contrary in the Indenture, upon the acceleration of the Notes in accordance with Section 502 of the Indenture, the amount immediately due and payable in respect of the Notes shall equal the Outstanding principal amount
thereof, plus accrued and unpaid interest, plus the Make-Whole Amount. 
 ARTICLE 5 

EFFECTIVENESS 
 Section 5.1 This Supplemental Indenture shall be effective for all purposes as of the date and time this Supplemental Indenture has been executed and delivered by the Company and the Trustee
in accordance with Article Nine of the Indenture. As supplemented hereby, the Indenture is hereby confirmed as being in full force and effect. 
 ARTICLE 6 
 NOTICE TO TRUSTEE 

Section 6.1 Notwithstanding anything to the contrary in the Indenture including, without limitation, Section 1102
thereof, in connection with the redemption at the election of the Company of less than all the Notes, the Company shall notify the Trustee of the establishment of a Redemption Date and the principal amount of Notes to be redeemed at least 60 days
prior to such Redemption Date unless a shorter period shall be satisfactory to the Trustee. 
 ARTICLE 7 

MISCELLANEOUS 
 Section 7.1 In the event any provision of this Supplemental Indenture shall be held invalid or unenforceable by any court of competent jurisdiction, such holding shall not invalidate or render
unenforceable any other provision hereof or any provision of the Indenture. 
 Section 7.2 To the extent that any
terms of this Supplemental Indenture or the Notes are inconsistent with the terms of the Indenture, the terms of this Supplemental Indenture or the Notes shall govern and supersede such inconsistent terms. 

Section 7.3 This Supplemental Indenture shall be governed by and construed in accordance with the laws of the State of New
York. 
 Section 7.4 This Supplemental Indenture may be executed in several counterparts, each of which shall be an
original and all of which shall constitute but one and the same instrument. 

  
 11 

 IN WITNESS WHEREOF, the Company and the Trustee have caused this Supplemental Indenture to
be executed in their respective corporate names as of the date first above written. 
  

			
	HEALTH CARE REIT, INC.
		
	By:	 	 /s/ George L. Chapman

	Name:	 	George L. Chapman
	Title:	 	Chairman, Chief Executive Officer and President
	
	 THE BANK OF NEW YORK MELLON TRUST
 COMPANY, N. A., as Trustee

		
	By:	 	 /s/ Richard Tarnas

	Name:	 	Richard Tarnas
	Title:	 	Vice President

 EXHIBIT A 
 FORM OF NOTE 
 [Form of Face of Security] 

HEALTH CARE REIT, INC. 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER,
EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS
IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

 2.250% Senior Notes due 2018 
  

			
	CUSIP No. 42217K AZ9	 	$450,000,000

 Health Care REIT, Inc., a corporation duly organized and existing under the laws of the State of Delaware
(herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of Four
Hundred Fifty Million Dollars on March 15, 2018, and to pay interest thereon from December 6, 2012, or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on
March 15 and September 15 in each year, commencing September 15, 2013 at the rate of 2.250% per annum, until the principal hereof is paid or made available for payment. The interest so payable, and punctually paid or duly
provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the Regular Record Date for such
interest, which shall be the March 1 or September 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be
payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such
Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the
requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 

  
 A-1

 Payment of the principal of (and premium, if any) and any such interest on this Security
will be made at the office or agency of the Company maintained for that purpose in the City of New York, New York, or elsewhere as provided in the Indenture, in such coin or currency of the United States of America as at the time of payment is legal
tender for payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register.

 Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions
shall for all purposes have the same effect as if set forth at this place. 
 No recourse under or upon any obligation, covenant
or agreement contained in the Indenture or in this Security, or because of any indebtedness evidenced hereby or thereby, shall be had against any promoter, as such, or against any past, present or future shareholder, officer or director, as such, of
the Company or of any successor, either directly or through the Company or any successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all
such liability being expressly waived and released by the acceptance of this Security by the Holder thereof and as part of the consideration for the issue of the Securities of this series. 

Unless the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature,
this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 
 In Witness
Whereof, the Company has caused this instrument to be duly executed under its corporate seal. 
  

					
	 HEALTH CARE REIT, INC.

			
		 	By:	 	  

		 	Name:	 	
		 	Title:	 	

  
 A-2

 CERTIFICATE OF AUTHENTICATION 
 Dated:                 
 This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 

 

			
	 THE BANK OF NEW YORK MELLON TRUST
 COMPANY, N. A., as Trustee

		
	By:	 	  

		 	Authorized Signatory

  
 A-3

 [Form of Reverse of Security] 

1. General. This Security is one of a duly authorized issue of securities of the Company (herein called the
“Securities”), issued and to be issued in one or more series under an Indenture, dated as of March 15, 2010 (as amended, supplemented or otherwise modified from time to time, the “Base Indenture”), as supplemented by
Supplemental Indenture No. 7, dated as of December 6, 2012, (as amended, supplemented or otherwise modified from time to time, the “Supplemental Indenture” and the Base Indenture, as supplemented by such Supplemental Indenture,
the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (herein called the “Trustee,” which term includes any successor trustee under the Indenture), and reference is hereby made to
the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee, the holders of Senior Debt and the Holders of the Securities and of the terms upon which the Securities are,
and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof. 
 2. Optional
Redemption. The Securities of this series are subject to redemption upon not less than 30 nor more than 60 days’ notice by mail, at any time or from time to time, as a whole or in part, at the election of the Company. If the Securities are
redeemed, the redemption price will equal the sum of (i) the principal amount of the Securities (or portion of such Securities) being redeemed, plus accrued and unpaid interest thereon to but excluding the applicable Redemption Date, and
(ii) the Make-Whole Amount, if any. 
 In the event of redemption of this Security in part only, a new Security or
Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof. 
 3. Defeasance. The Indenture contains provisions for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect to this
Security, in each case upon compliance with certain conditions set forth in the Indenture. 
 4. Defaults and Remedies.
If an Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture. 

5. Actions of Holders. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the
modification of the rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of a majority in
principal amount of the Securities at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the time
Outstanding, on behalf of the Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences.

  
 A-4

 
Any such consent or waiver by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the
registration of transfer hereof or in exchange therefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Security. 
 As provided in and subject to the provisions of the Indenture, the Holder of this Security shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a
receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect to the Securities of this series, the Holders of not less than a majority
in principal amount of the Securities of this series at the time Outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default as Trustee and offered the Trustee reasonable indemnity, and the
Trustee shall not have received from the Holders of a majority in principal amount of Securities of this series at the time Outstanding a direction inconsistent with such request, and shall have failed to institute any such proceeding, for 60 days
after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Security for the enforcement of any payment of principal hereof or any premium or interest hereon on or after
the respective due dates expressed herein. 
 6. Payments Not Impaired. No reference herein to the Indenture and no
provision of this Security or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the
coin or currency, herein prescribed. 
 7. Denominations, Transfer, Exchange. As provided in the Indenture and subject to
certain limitations therein set forth, the transfer of this Security is registrable in the Security Register, upon surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and
any premium and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly
authorized in writing, and thereupon one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 

The Securities of this series are issuable only in registered form without coupons in minimum denominations of $2,000 and any integral
multiple of $1,000. As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different
authorized denomination, as requested by the Holder surrendering the same. 
 No service charge shall be made for any such
registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 
 8. Persons Deemed Owners. Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the

  
 A-5

 
Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be
affected by notice to the contrary. 
 9. Defined Terms. All terms used in this Security which are defined in the
Indenture shall have the meanings assigned to them in the Indenture. 
 10. Governing Law. The Indenture and the Note
shall be deemed to be a contract made under the laws of the State of New York, and for all purposes shall be construed in accordance with the laws of said state. 
 11. CUSIP Number. Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be printed on the Securities as a
convenience to the Holders of the Securities. No representation is made as to the correctness or accuracy of such CUSIP numbers as printed on the Securities, and reliance may be placed only on the other identification numbers printed hereon.

  
 A-6

 [ASSIGNMENT FORM] 

ABBREVIATIONS 
 The following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out in full according to applicable laws or regulations:

  

							
	 TEN COM —
 TEN
ENT —
 JT TEN —
	  	 as tenants in common
 as
tenants by the entireties
 as joint tenants with right of survivorship and not as tenants in common
	  	UNIF GIFT MIN ACT —	  	                     
Custodian                 

(Cust)                        
        (Minor)
 Under Uniform Gifts to Minors Act

                        

 (State)

 Additional abbreviations may also be used though not in the above list. 

 

                         
                            
 FOR VALUE RECEIVED, the undersigned registered holder hereby sell(s), assign(s) and transfer(s) unto 
  

 
 PLEASE INSERT SOCIAL SECURITY OR OTHER
IDENTIFYING NUMBER OF ASSIGNEE 
  
  

PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS OF ASSIGNEE 
 the within security and all rights thereunder, hereby irrevocably constituting and appointing
                                         
                        Attorney to transfer said security on the books of the Company with full power of substitution in the
premises. 
  

							
	Dated:                     	 		 	Signed:	 	  

			
		 	        	 	Notice: The signature to this assignment must correspond with the name as it appears upon the face of the within security in every particular, without alteration or
enlargement or any change whatever.

							
				
		 		 	Signature Guarantee*:	 	  

			
		 		 	* Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee).

  
 A-7

 EXHIBIT B 
 FORM OF NOTE 
 [Form of Face of Security] 

HEALTH CARE REIT, INC. 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER,
EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS
IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

 3.750% Senior Notes due 2023 
  

			
	CUSIP No. 42217K BA3	  	$500,000,000

 Health Care REIT, Inc., a corporation duly organized and existing under the laws of the State of Delaware
(herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of Five
Hundred Million Dollars on March 15, 2023, and to pay interest thereon from December 6, 2012, or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on March 15 and
September 15 in each year, commencing September 15, 2013 at the rate of 3.750% per annum, until the principal hereof is paid or made available for payment. The interest so payable, and punctually paid or duly provided for, on any
Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be
the March 1 or September 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the Holder on
such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed
by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities
exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 

  
 B-1

 Payment of the principal of (and premium, if any) and any such interest on this Security
will be made at the office or agency of the Company maintained for that purpose in the City of New York, New York, or elsewhere as provided in the Indenture, in such coin or currency of the United States of America as at the time of payment is legal
tender for payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register.

 Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions
shall for all purposes have the same effect as if set forth at this place. 
 No recourse under or upon any obligation, covenant
or agreement contained in the Indenture or in this Security, or because of any indebtedness evidenced hereby or thereby, shall be had against any promoter, as such, or against any past, present or future shareholder, officer or director, as such, of
the Company or of any successor, either directly or through the Company or any successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all
such liability being expressly waived and released by the acceptance of this Security by the Holder thereof and as part of the consideration for the issue of the Securities of this series. 

Unless the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature,
this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 
 In Witness
Whereof, the Company has caused this instrument to be duly executed under its corporate seal. 
  

					
	HEALTH CARE REIT, INC.
			
		 	By:	 	  

		 	Name:	 	
		 	Title:	 	

  
 B-2

 CERTIFICATE OF AUTHENTICATION 

Dated:                      

This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 

 

			
	 THE BANK OF NEW YORK MELLON TRUST
 COMPANY, N. A., as Trustee

		
	By:	 	  

		 	    Authorized Signatory

  
 B-3

 [Form of Reverse of Security] 

1. General. This Security is one of a duly authorized issue of securities of the Company (herein called the
“Securities”), issued and to be issued in one or more series under an Indenture, dated as of March 15, 2010 (as amended, supplemented or otherwise modified from time to time, the “Base Indenture”), as supplemented by
Supplemental Indenture No. 7, dated as of December 6, 2012, (as amended, supplemented or otherwise modified from time to time, the “Supplemental Indenture” and the Base Indenture, as supplemented by such Supplemental Indenture,
the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (herein called the “Trustee,” which term includes any successor trustee under the Indenture), and reference is hereby made to
the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee, the holders of Senior Debt and the Holders of the Securities and of the terms upon which the Securities are,
and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof. 
 2. Optional
Redemption. The Securities of this series are subject to redemption upon not less than 30 nor more than 60 days’ notice by mail, at any time or from time to time, as a whole or in part, at the election of the Company. If the Securities are
redeemed, the redemption price will equal the sum of (i) the principal amount of the Securities (or portion of such Securities) being redeemed, plus accrued and unpaid interest thereon to but excluding the applicable Redemption Date, and
(ii) the Make-Whole Amount, if any; provided, however, that if the Securities of this series are redeemed 90 or fewer days prior to their maturity date, the redemption price will equal 100% of the principal amount of the Securities of this
series (or portion of such Securities) being redeemed plus accrued and unpaid interest thereon to but excluding the Redemption Date. 
 In the event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof
upon the cancellation hereof. 
 3. Defeasance. The Indenture contains provisions for defeasance at any time of the
entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect to this Security, in each case upon compliance with certain conditions set forth in the Indenture. 

4. Defaults and Remedies. If an Event of Default with respect to Securities of this series shall occur and be continuing, the
principal of the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture. 
 5. Actions of Holders. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of
the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the time Outstanding of each series to
be 

  
 B-4

 
affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the time Outstanding, on behalf of the
Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security
shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange therefor or in lieu hereof, whether or not notation of such consent or
waiver is made upon this Security. 
 As provided in and subject to the provisions of the Indenture, the Holder of this Security
shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a
continuing Event of Default with respect to the Securities of this series, the Holders of not less than a majority in principal amount of the Securities of this series at the time Outstanding shall have made written request to the Trustee to
institute proceedings in respect of such Event of Default as Trustee and offered the Trustee reasonable indemnity, and the Trustee shall not have received from the Holders of a majority in principal amount of Securities of this series at the time
Outstanding a direction inconsistent with such request, and shall have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the
Holder of this Security for the enforcement of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed herein. 
 6. Payments Not Impaired. No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the Company, which is absolute and
unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed. 
 7. Denominations, Transfer, Exchange. As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the Security Register, upon
surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of
transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like tenor, of authorized
denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 
 The
Securities of this series are issuable only in registered form without coupons in minimum denominations of $2,000 and any integral multiple of $1,000. As provided in the Indenture and subject to certain limitations therein set forth, Securities of
this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering the same. 

  
 B-5

 No service charge shall be made for any such registration of transfer or exchange, but the
Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

8. Persons Deemed Owners. Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any
agent of the Company or the Trustee may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be
affected by notice to the contrary. 
 9. Defined Terms. All terms used in this Security which are defined in the
Indenture shall have the meanings assigned to them in the Indenture. 
 10. Governing Law. The Indenture and the Note
shall be deemed to be a contract made under the laws of the State of New York, and for all purposes shall be construed in accordance with the laws of said state. 
 11. CUSIP Number. Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be printed on the Securities as a
convenience to the Holders of the Securities. No representation is made as to the correctness or accuracy of such CUSIP numbers as printed on the Securities, and reliance may be placed only on the other identification numbers printed hereon.

  
 B-6

 [ASSIGNMENT FORM] 

ABBREVIATIONS 
 The following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out in full according to applicable laws or regulations:

  

							
	 TEN COM —
 TEN
ENT —
 JT TEN —
	  	 as tenants in common
 as
tenants by the entireties
 as joint tenants with right of survivorship and not as tenants in common
	  	UNIF GIFT MIN ACT —	  	                     
Custodian                 

(Cust)                        
        (Minor)
 Under Uniform Gifts to Minors Act

                        

 (State)

 Additional abbreviations may also be used though not in the above list. 

 

                         
                            
 FOR VALUE RECEIVED, the undersigned registered holder hereby sell(s), assign(s) and transfer(s) unto 
  

 
 PLEASE INSERT SOCIAL SECURITY OR OTHER
IDENTIFYING NUMBER OF ASSIGNEE 
  
  

PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS OF ASSIGNEE 
 the within security and all rights thereunder, hereby irrevocably constituting and appointing
                                         
                        Attorney to transfer said security on the books of the Company with full power of substitution in the
premises. 
  

							
	Dated:                     	 		 	Signed:	 	  

			
		 		 	Notice: The signature to this assignment must correspond with the name as it appears upon the face of the within security in every particular, without alteration or
enlargement or any change whatever.

							
				
		 		 	Signature Guarantee*:	 	  

			
		 		 	* Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee).

  
 B-7

 EXHIBIT C 
 FORM OF NOTE 
 [Form of Face of Security] 

HEALTH CARE REIT, INC. 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER,
EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS
IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

 5.125% Senior Notes due 2043 
  

			
	 CUSIP No. 42217K BB1
	 	$250,000,000

 Health Care REIT, Inc., a corporation duly organized and existing under the laws of the State of Delaware
(herein called the “Company,” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of Two Hundred
Fifty Million Dollars on March 15, 2043, and to pay interest thereon from December 6, 2012, or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually in arrears on March 15 and
September 15 in each year, commencing September 15, 2013 at the rate of 5.125% per annum, until the principal hereof is paid or made available for payment. The interest so payable, and punctually paid or duly provided for, on any
Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be
the March 1 or September 1 (whether or not a Business Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the Holder on
such Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed
by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities
exchange on which the Securities of this series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture. 

  
 C-1

 Payment of the principal of (and premium, if any) and any such interest on this Security
will be made at the office or agency of the Company maintained for that purpose in the City of New York, New York, or elsewhere as provided in the Indenture, in such coin or currency of the United States of America as at the time of payment is legal
tender for payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register.

 Reference is hereby made to the further provisions of this Security set forth on the reverse hereof, which further provisions
shall for all purposes have the same effect as if set forth at this place. 
 No recourse under or upon any obligation, covenant
or agreement contained in the Indenture or in this Security, or because of any indebtedness evidenced hereby or thereby, shall be had against any promoter, as such, or against any past, present or future shareholder, officer or director, as such, of
the Company or of any successor, either directly or through the Company or any successor, under any rule of law, statute or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all
such liability being expressly waived and released by the acceptance of this Security by the Holder thereof and as part of the consideration for the issue of the Securities of this series. 

Unless the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature,
this Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 
 In Witness
Whereof, the Company has caused this instrument to be duly executed under its corporate seal. 
  

					
	HEALTH CARE REIT, INC.
			
		 	By:	 	  

		 	Name:	 	
		 	Title:	 	

  
 C-2

 CERTIFICATE OF AUTHENTICATION 

Dated:                      

This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 

 

			
	 THE BANK OF NEW YORK MELLON TRUST
 COMPANY, N. A., as Trustee

		
	By:	 	  

		 	    Authorized Signatory

  
 C-3

 [Form of Reverse of Security] 

1. General. This Security is one of a duly authorized issue of securities of the Company (herein called the
“Securities”), issued and to be issued in one or more series under an Indenture, dated as of March 15, 2010 (as amended, supplemented or otherwise modified from time to time, the “Base Indenture”), as supplemented by
Supplemental Indenture No. 7, dated as of December 6, 2012, (as amended, supplemented or otherwise modified from time to time, the “Supplemental Indenture” and the Base Indenture, as supplemented by such Supplemental Indenture,
the “Indenture”), between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (herein called the “Trustee,” which term includes any successor trustee under the Indenture), and reference is hereby made to
the Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee, the holders of Senior Debt and the Holders of the Securities and of the terms upon which the Securities are,
and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof. 
 2. Optional
Redemption. The Securities of this series are subject to redemption upon not less than 30 nor more than 60 days’ notice by mail, at any time or from time to time, as a whole or in part, at the election of the Company. If the Securities are
redeemed, the redemption price will equal the sum of (i) the principal amount of the Securities (or portion of such Securities) being redeemed, plus accrued and unpaid interest thereon to but excluding the applicable Redemption Date, and
(ii) the Make-Whole Amount, if any; provided, however, that if the Securities of this series are redeemed 180 or fewer days prior to their maturity date, the redemption price will equal 100% of the principal amount of the Securities of this
series (or portion of such Securities) being redeemed plus accrued and unpaid interest thereon to but excluding the Redemption Date. 
 In the event of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof
upon the cancellation hereof. 
 3. Defeasance. The Indenture contains provisions for defeasance at any time of the
entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect to this Security, in each case upon compliance with certain conditions set forth in the Indenture. 

4. Defaults and Remedies. If an Event of Default with respect to Securities of this series shall occur and be continuing, the
principal of the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture. 
 5. Actions of Holders. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of
the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of a majority in principal amount of the Securities at the time Outstanding of each series to
be 

  
 C-4

 
affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the time Outstanding, on behalf of the
Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security
shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange therefor or in lieu hereof, whether or not notation of such consent or
waiver is made upon this Security. 
 As provided in and subject to the provisions of the Indenture, the Holder of this Security
shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a
continuing Event of Default with respect to the Securities of this series, the Holders of not less than a majority in principal amount of the Securities of this series at the time Outstanding shall have made written request to the Trustee to
institute proceedings in respect of such Event of Default as Trustee and offered the Trustee reasonable indemnity, and the Trustee shall not have received from the Holders of a majority in principal amount of Securities of this series at the time
Outstanding a direction inconsistent with such request, and shall have failed to institute any such proceeding, for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the
Holder of this Security for the enforcement of any payment of principal hereof or any premium or interest hereon on or after the respective due dates expressed herein. 
 6. Payments Not Impaired. No reference herein to the Indenture and no provision of this Security or of the Indenture shall alter or impair the obligation of the Company, which is absolute and
unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed. 
 7. Denominations, Transfer, Exchange. As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the Security Register, upon
surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of
transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like tenor, of authorized
denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. 
 The
Securities of this series are issuable only in registered form without coupons in minimum denominations of $2,000 and any integral multiple of $1,000. As provided in the Indenture and subject to certain limitations therein set forth, Securities of
this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the Holder surrendering the same. 

  
 C-5

 No service charge shall be made for any such registration of transfer or exchange, but the
Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. 

8. Persons Deemed Owners. Prior to due presentment of this Security for registration of transfer, the Company, the Trustee and any
agent of the Company or the Trustee may treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be
affected by notice to the contrary. 
 9. Defined Terms. All terms used in this Security which are defined in the
Indenture shall have the meanings assigned to them in the Indenture. 
 10. Governing Law. The Indenture and the Note
shall be deemed to be a contract made under the laws of the State of New York, and for all purposes shall be construed in accordance with the laws of said state. 
 11. CUSIP Number. Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP numbers to be printed on the Securities as a
convenience to the Holders of the Securities. No representation is made as to the correctness or accuracy of such CUSIP numbers as printed on the Securities, and reliance may be placed only on the other identification numbers printed hereon.

  
 C-6

 [ASSIGNMENT FORM] 

ABBREVIATIONS 
 The following abbreviations, when used in the inscription on the face of this instrument, shall be construed as though they were written out in full according to applicable laws or regulations:

  

							
	 TEN COM —
 TEN
ENT —
 JT TEN —
	  	 as tenants in common
 as
tenants by the entireties
 as joint tenants with right of survivorship and not as tenants in common
	  	UNIF GIFT MIN ACT —	  	                     
Custodian                 

(Cust)                        
        (Minor)
 Under Uniform Gifts to Minors Act

                        

 (State)

 Additional abbreviations may also be used though not in the above list. 

 

                         
                            
 FOR VALUE RECEIVED, the undersigned registered holder hereby sell(s), assign(s) and transfer(s) unto 
  

 
 PLEASE INSERT SOCIAL SECURITY OR OTHER
IDENTIFYING NUMBER OF ASSIGNEE 
  
  

PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS OF ASSIGNEE 
 the within security and all rights thereunder, hereby irrevocably constituting and appointing
                                         
                        Attorney to transfer said security on the books of the Company with full power of substitution in the
premises. 
  

							
	Dated:	 		 	Signed:	 	  

			
		 		 	Notice: The signature to this assignment must correspond with the name as it appears upon the face of the within security in every particular, without alteration or
enlargement or any change whatever.

							
				
		 		 	Signature Guarantee*:	 	  

			
		 		 	* Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee).

  
 C-7Form of Omnibus Agreement

 Exhibit 10.2 
 FORM OF OMNIBUS AGREEMENT 

 TABLE OF CONTENTS 

 

					
	ARTICLE 1	  	 	 
	DEFINITIONS	  			
		
	 Section 1.1 Definitions
	  	 	2	  
	ARTICLE 2	  			
	INTELLECTUAL PROPERTY LICENSE	  			
		
	 Section 2.1 License Grant
	  	 	9	  
	 Section 2.2 Restrictions and Additional Agreements with Respect to License
	  	 	9	  
	 Section 2.3 Covenants of Licensor and Licensees
	  	 	10	  
	 Section 2.4 Intellectual Property Indemnification
	  	 	11	  
		
	 ARTICLE 3
 INDEMNIFICATION
	  			
		
	 Section 3.1 Sponsor’s Environmental Indemnification Obligations
	  	 	11	  
	 Section 3.2 Partnership Group’s Indemnification Obligations
	  	 	11	  
	 Section 3.3 Additional Indemnification
	  	 	12	  
	 Section 3.4 Limitations Regarding Indemnification
	  	 	12	  
	 Section 3.5 Indemnification Procedures
	  	 	13	  
	 Section 3.6 In the Event of Termination
	  	 	14	  
		
	ARTICLE 4	  			
	AGREEMENT WITH RESPECT TO CUSTOMER CONTRACTS	  			
		
	 Section 4.1 Assumption of Customer Obligations by Sponsor
	  	 	14	  
	 Section 4.2 Allocation of Amounts Recovered under Coke Sales Agreements
	  	 	15	  
	 Section 4.3 Term of Agreement with Respect to Customer Contracts
	  	 	15	  
		
	 ARTICLE 5
 BUSINESS OPPORTUNITIES
	  			
	 Section 5.1 Preferential Rights
	  	 	16	  
	 Section 5.2 Permitted Exceptions
	  	 	16	  
	 Section 5.3 Business Opportunities Procedures
	  	 	16	  
		
	ARTICLE 6	  			
	RIGHT OF FIRST OFFER	  			
		
	 Section 6.1 Right of First Offer to Purchase Certain Assets
	  	 	18	  
	 Section 6.2 Procedures
	  	 	18	  
		
	ARTICLE 7	  			
	EXPENSES AND REIMBURSEMENT OBLIGATIONS	  			
		
	 Section 7.1 Provision of General and Administrative Services
	  	 	19	  

  
 i 

					
	 Section 7.2   Reimbursement and Allocation
	  	 	19	  
	 Section 7.3   Debt Financing Fees
	  	 	20	  
	ARTICLE 8	  			
	MISCELLANEOUS	  			
		
	 Section 8.1   Choice of Law; Submission to Jurisdiction
	  	 	20	  
	 Section 8.2   Notice
	  	 	20	  
	 Section 8.3   Entire Agreement
	  	 	21	  
	 Section 8.4   Termination
	  	 	21	  
	 Section 8.5   Effect of Waiver or Consent
	  	 	21	  
	 Section 8.6   Amendment or Modification
	  	 	21	  
	 Section 8.7   Assignment; Third Party Beneficiaries
	  	 	22	  
	 Section 8.8   Counterparts
	  	 	22	  
	 Section 8.9   Severability
	  	 	22	  
	 Section 8.10 Gender, Parts, Articles and Sections
	  	 	22	  
	 Section 8.11 Further Assurances
	  	 	22	  
	 Section 8.12 Withholding or Granting of Consent
	  	 	22	  
	 Section 8.13 Laws and Regulations
	  	 	23	  
	 Section 8.14 Negation of Rights of Limited Partners, Assignees and Third Parties
	  	 	23	  
	 Section 8.15 No Recourse Against Officers and Directors
	  	 	23	  
	 Section 8.16 Arbitration
	  	 	23	  
	 Section 8.17 Dispute Resolution
	  	 	23	  

 SCHEDULES 
  

	Schedule 2(a)	Mark Intellectual Property 

	Schedule 2(b)	Patent Rights 

	Schedule 3.1	Known Remediation Losses 

	Schedule 4.2	Coke Sales Agreements 

	Schedule 7.2	Allocation of Overhead Costs and Expenses 

  
 ii 

 FORM OF OMNIBUS AGREEMENT 

THIS OMNIBUS AGREEMENT (this “Agreement”), as it may be amended, modified or supplemented from time to time in
accordance with the terms hereof, is entered into effective as of [            ], 2013 (the “Effective Date”), and is by and among SUNCOKE ENERGY PARTNERS, L.P., a Delaware
limited partnership (the “Partnership”), SUNCOKE ENERGY PARTNERS GP LLC, a Delaware limited liability company and the general partner of the Partnership (the “General Partner”), and SUNCOKE ENERGY, INC., a Delaware
corporation (the “Sponsor”). The above-named entities are sometimes referred to in this Agreement each as a “Party” and collectively as the “Parties.” 

RECITALS: 

WHEREAS, pursuant to the Contribution Agreement in connection with the Initial Public Offering, the Sponsor will cause Sun
Coal & Coke LLC (“SC&C”) to contribute to the Partnership an interest in each of Haverhill Coke Company LLC, a Delaware limited liability company (“Haverhill”) and Middletown Coke Company, LLC, a
Delaware limited liability company (“Middletown”) (the “Sun Coal & Coke Contribution”) which will result in the Partnership owning a 65% interest in each of Haverhill and Middletown, and in exchange
(1) the General Partner will receive a 2.0% General Partner Interest (as defined herein) and the Incentive Distribution Rights (as defined herein), (2) SC&C will receive
[            ] Common Units (as defined herein), [            ] Subordinated Units (as defined herein) and the right to receive
the Deferred Issuance and Distribution (as defined herein), (3) the Partnership will assume and promptly repay, with the net proceeds of the Initial Public Offering and the Senior Notes Offering,
$[            ] million of debt under the Sponsor’s term loan, and (4) the Partnership will pay, with the net proceeds of the Initial Public Offering, 100% of (A) an
aggregate of $[ ] million of environmental capital expenditures of Haverhill and Middletown, (B) an aggregate of approximately $[            ] million sale discounts related to tax
credits owed to customers of Haverhill and Middletown, and (C) $[            ] million to replenish the Partnership’s working capital (the transactions described in clauses
(1)-(4) and the Sun Coal & Coke Contribution, the “IPO Transactions”); and 
 WHEREAS, in
connection with the IPO Transactions, the Parties desire by their execution of this Agreement to evidence their understanding as more fully set forth in this Agreement, with respect to (1) the Partnership’s and its Subsidiaries’
rights to use certain intellectual property pursuant to a license granted by the Sponsor; (2) specified indemnification obligations of the Sponsor and the Partnership; (3) the rights and obligations of the Parties in the event that a
customer’s purchase and payment obligations under a Coke Sales Agreement (as defined herein) are reduced or if a customer fails to satisfy such obligations; (4) those business opportunities (A) that the Sponsor Entities (as defined
herein) will not engage in, directly or indirectly, during the term of this Agreement unless the Partnership declines to engage in such business opportunities for its own account or on behalf of its Subsidiaries, and (B) that no Group Member
will engage in, directly or indirectly, during the term of this Agreement unless the Sponsor declines to engage in such business opportunities for its own account or on behalf of its controlled Affiliates; (5) the Parties’ right of first
offer with respect to the ROFO Assets (as defined herein); and (6) the allocation of certain selling, general and administrative expenses as between the Partnership and the Sponsor. 

 NOW, THEREFORE, in consideration of the premises and the covenants, conditions and
agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: 
 ARTICLE 1 
 DEFINITIONS 

Section 1.1 Definitions As used in this Agreement, the following terms have the respective meanings set forth below:

 “Affiliate” means, with respect to any Person, any other Person who directly or indirectly controls, is
controlled by, or is under direct or indirect common control with, such Person, and includes any Person in like relation to an Affiliate. A Person shall be deemed to “control” another Person if such Person possesses, directly or
indirectly, the power to direct or cause the direction of the management and policies of such other Person, whether through the ownership of voting securities, by contract or otherwise; and the term “controlled” shall have a similar
meaning. Without limiting the generality of the foregoing, it is agreed that any Person that owns or controls, directly or indirectly, 50% or more of the voting securities of another Person shall be deemed for purposes of this Agreement to control
such other Person. 
 “Agreement” has the meaning given such term in the introduction to this Agreement.

 “AK Steel” means AK Steel Corporation, a Delaware corporation, its successors and assigns. 

“AK Steel Coke Agreement” means the Coke Purchase Agreement, dated as of August 31, 2009, by and between Haverhill
and AK Steel, as amended by Amendment No. 1 to Coke Purchase Agreement, dated as of May 8, 2012, as may be amended from time to time . 
 “AK Steel Obligations” means the obligations of AK Steel under the AK Steel Coke Agreement as in effect on the Closing Date, including but not limited to the obligations to purchase and
pay for coke. 
 “Arbitration Award” has the meaning given such term in Section 8.16. 

“Business Opportunity Notice” has the meaning given such term in Section 5.3(a). 

“Cause” has the meaning given such term in the Partnership Agreement. 

“Change of Control” means, with respect to any Person (the “Applicable Person”), any of the following
events: 
 (a) any sale, lease, exchange or other transfer (in one transaction or a series of related
transactions) of all or substantially all of the Applicable Person’s assets to any other Person, unless immediately following such sale, lease, exchange or other transfer such assets are owned, directly or indirectly, by the Applicable Person;

 (b) the dissolution or liquidation of the Applicable Person; 

  
 2 

 (c) the consolidation or merger of the Applicable Person with or into
another Person, other than any such transaction where: 
 (i) the outstanding Voting Securities of the Applicable
Person are changed into or exchanged for Voting Securities of the surviving Person or its parent; and 
 (ii) the
holders of the Voting Securities of the Applicable Person immediately prior to such transaction own, directly or indirectly, not less than a majority of the outstanding Voting Securities of the surviving Person or its parent immediately after such
transaction; or 
 (d) a “person” or “group” (within the meaning of Sections 13(d) or
14(d)(2) of the Exchange Act) being or becoming the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act) of more than 50% of all of the then outstanding Voting Securities of the Applicable Person, except in a
merger or consolidation that would not constitute a Change of Control under clause (c) above. 
 “Closing
Date” means the date of the closing of the Initial Public Offering. 
 “Coke Sales Agreements” means
the agreements identified on Schedule 4.2 hereto, as the same may be amended from time to time. 
 “Commercial
Operations Notice” has the meaning given such term in Section 5.3(b) 
 “Common Units” has the
meaning given such term in the Partnership Agreement. 
 “Conflicts Committee” has the meaning given such term
in the Partnership Agreement. 
 “Contribution Agreement” means that certain Contribution, Conveyance and
Assumption Agreement, dated as of [            ], 2013, among the General Partner, the Partnership, SC&C and certain other parties, together with the additional conveyance documents and
instruments contemplated or referenced thereunder, as such may be amended, supplemented or restated from time to time. 

“Deferred Issuance and Distribution” has the meaning given such term in the Partnership Agreement. 

“Discussion Date” has the meaning given such term in Section 8.17. 

“Domestic Cokemaking Asset” means a cokemaking facility in the United States or Canada or an interest in a business that
is primarily engaged in cokemaking operations in the United States and/or Canada. “Domestic Cokemaking Asset” shall not include an interest in a business that is engaged in cokemaking operations if the Sponsor determines in good
faith that such cokemaking operations represent a minority of the value of the business. 
 “Effective Date”
has the meaning given such term in the introduction to this Agreement. 

  
 3 

 “Environmental Laws” means all applicable federal, regional, state, and
local laws, statutes, rules, regulations, orders, ordinances, judgments, codes, injunctions, decrees, permits and other legally enforceable requirements and rules of common law relating to (i) pollution or protection of human health, the
environment or natural resources; (ii) any Release or threatened Release of, or exposure to, Hazardous Substances; (iii) greenhouse gas emissions or (iv) the generation, manufacture, processing, distribution, use, treatment, storage,
disposal, transport, arrangement for disposal or transport, handling or Release of any Hazardous Substances. Without limiting the foregoing, “Environmental Laws” include, without limitation, the federal Comprehensive Environmental
Response, Compensation, and Liability Act, the Resource Conservation and Recovery Act, the Clean Air Act, the Clean Water Act, the Safe Drinking Water Act, the Endangered Species Act, the Toxic Substances Control Act, the Occupational Safety and
Health Act and other environmental conservation and protection laws, each as amended through the Closing Date. 

“Environmental Losses” means any Loss suffered or incurred by reason of or arising out of (i) any violation or
correction of violation of Environmental Laws; or (ii) any event, circumstance, action, omission, condition or environmental matter (including, without limitation, the exposure to, presence of, Release or threatened Release of Hazardous
Substances) including, without limitation, (A) the cost and expense of any investigation, assessment, evaluation, response, abatement, monitoring, containment, cleanup, repair, restoration, remediation, or other corrective action required or
necessary under Environmental Laws or to satisfy any applicable Voluntary Cleanup Program, (B) the performance of a supplemental environmental project authorized or consented to by a Governmental Authority in partial or whole mitigation of a
fine or penalty, (C) the cost or expense of the preparation and implementation of any investigatory closure, remedial or corrective action or other plans required or necessary under Environmental Laws or to satisfy any applicable Voluntary
Cleanup Program and (D) the cost and expense for any environmental or toxic tort pre-trial, trial, or appellate legal or litigation support work. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
 “General Partner” has the meaning given such term in the introduction to this Agreement. 
 “General Partner Interest” has the meaning given such term in the Partnership Agreement. 
 “Governmental Authority” means: 
 (a) any domestic
or foreign government, whether national, federal, state provincial, territorial, municipal or local (whether administrative, legislative, executive or otherwise); 

(b) any agency, authority, ministry, department, regulatory body, court, central bank, bureau, board or other
instrumentality having legislative, judicial, taxing, regulatory, prosecutorial or administrative powers or functions of, or pertaining to, government; 

  
 4 

 (c) any court, tribunal, commission, individual, arbitrator, arbitration
panel or other body having adjudicative, regulatory, judicial, quasi-judicial, administrative or similar functions; and 
 (d) any other body or entity created under the authority of or otherwise subject to the jurisdiction of any of the foregoing, including any stock or other securities exchange or professional association.

 “Group Member” means a member of the Partnership Group. 

“Haverhill” has the meaning set forth in the Recitals to this Agreement. 

“Hazardous Substance” means (i) any substance that is designated, defined or classified as a hazardous waste, solid
waste, hazardous material, pollutant, contaminant or toxic or hazardous substance, or terms of similar meaning, or that is otherwise regulated by, or as to which liability may attach under any Environmental Law, including, without limitation, any
hazardous substance as such term is defined under the federal Comprehensive Environmental Response, Compensation, and Liability Act, as amended through the Closing Date, (ii) radioactive materials, asbestos or asbestos containing materials,
polychlorinated biphenyls, urea formaldehyde insulation, toxic mold or radon and (iii) oil as defined in the OPA of 1990, as amended, including oil, gasoline, fuel oil, motor oil, waste oil, diesel fuel, jet fuel, other refined petroleum
hydrocarbon and petroleum products. 
 “Implemented Improvements” has the meaning given such term in
Section 2.2(c). 
 “Improvements” means any technical development, improvement, refinement, advancement or
optimization made to the Non-Mark Intellectual Property made on or after the Effective Date. 
 “Incentive Distribution
Rights” has the meaning given such term in the Partnership Agreement. 
 “Indemnified Party” means
either the Partnership Group or the Sponsor, as the case may be, each in its capacity as a party entitled to indemnification in accordance with Article 3 hereof. 
 “Indemnifying Party” means either the Partnership Group or the Sponsor, as the case may be, each in its capacity as a party from whom indemnification may be required in accordance with
Article 3 hereof. 
 “Initial Public Offering” means the initial public offering of Common Units of the
Partnership. 
 “Intellectual Property” means, collectively, the Mark Intellectual Property, the Non-Mark
Intellectual Property and the Improvements. 
 “IPO Transactions” has the meaning set forth in the Recitals to
this Agreement. 

  
 5 

 “Kentucky Facility” means the opportunity to develop a new heat recovery
cokemaking facility in Kentucky with respect to which, as of the Effective Date, the Sponsor is in discussions with steelmakers and certain Governmental Authorities. 
 “Known Remediation Losses” has the meaning given such term in Section 3.1(a). 
 “Licensees” means, collectively, the Partnership Entities. 

“Licensed Uses” means the production and sale of coke and by-products of the cokemaking process. 

“Licensor” means the Sponsor. 
 “Losses” means all losses, damages, liabilities (including, without limitation, tax liabilities), claims, demands, causes of action, judgments, settlements, fines, penalties, costs and
expenses (including, without limitation, court costs and reasonable attorney’s and experts’ fees) of any and every kind or character, known or unknown, fixed or contingent. 

“Mark Intellectual Property” means the names and trademarks listed on Schedule 2(a) and any names and trademarks
confusingly similar thereto. 
 “Middletown” has the meaning set forth in the Recitals to this Agreement.

 “MLP Credit Agreement” means the Credit Agreement, dated as of
[            ], 2013, among the Partnership, Haverhill, Middletown, Haverhill Cogeneration Company LLC, Middletown Cogeneration Company LLC, and certain other subsidiaries of the
Partnership as joint and several Borrowers, and JPMorgan Chase Bank, N.A., as Administrative Agent. 
 “Non-Mark
Intellectual Property” means all foreign and domestic intellectual property and proprietary rights owned or controlled by Licensor, including, without limitation: (a) all Patent Rights; (b) all copyrights and registrations and
applications for registrations thereof; and (c) all trade secret and other confidential or proprietary information, including all rights in confidential computer programs, improvements, methods, processes, routines, data, manuals, systems,
procedures, practices, operations, modes of operation, apparatus, equipment, business opportunities, customer and supplier lists, process design, financial information, equipment drawings, technical specifications, processes, process measurements,
technical reports, analyses, plans, drawings, models, ideas, and correspondence. 
 “Organizational Documents”
means certificates or articles of incorporation, by-laws, certificates of formation, limited liability company operating agreements, certificates of limited partnership, limited partnership agreements or other formation or governing documents of a
particular entity. 
 “Partnership” has the meaning given such term in the introduction to this Agreement.

 “Partnership Agreement” means the First Amended and Restated Agreement of Limited Partnership of the
Partnership, as it may be amended from time to time. 

  
 6 

 “Partnership Assets” means all assets of the Partnership Group as of the
Closing Date. 
 “Partnership Covered Environmental Losses” has the meaning given such term in
Section 3.2. 
 “Partnership Entities” means the General Partner and each entity that is or becomes a
member of the Partnership Group for so long as it is a member of the Partnership Group; and “Partnership Entity” means any of the Partnership Entities. 
 “Partnership Group” means the Partnership and its Subsidiaries. 

“Partnership ROFO Assets” has the meaning given such term in Section 6.2(a). 

“Party” or “Parties” have the meaning given such term in the introduction to this Agreement.

 “Patent Rights” means any and all patents and patent applications, including, without limitation, those
listed on Schedule 2(b), certificates of invention, or applications for certificates of invention and any supplemental protection certificates, together with any extensions, registrations, confirmations, reissues, substitutions, divisions,
continuations or continuations-in-part, reexaminations or renewals thereof, whenever and wherever submitted, filed, issued, received, or granted claiming priority to any patent or patent application listed on Schedule 2(b). 

“Person” is to be construed broadly and includes an individual, partnership, limited partnership, corporation, business
trust, limited liability company, limited liability partnership, joint stock company, trust, unincorporated association, joint venture or other entity or a Governmental Authority. 

“Proposed Transaction” has the meaning given such term in Section 6.2(a). 

“Release” or “Releasing” means depositing, spilling, leaking, pumping, pouring, placing, emitting,
discarding, abandoning, emptying, discharging, migrating, injecting, escaping, leaking, dumping or disposing into the environment, including, without limitation, the abandonment or disposal of any barrels, containers or other closed receptacles
containing any Hazardous Substance. 
 “Representatives” means the directors, officers, employees, advisors,
consultants, contractors or agents employed or otherwise retained by Licensees. 
 “Retained Assets” means the
assets and investments owned by Sponsor or any of its Affiliates that were not conveyed, contributed or otherwise transferred to the Partnership Group pursuant the Contribution Agreement. 

“ROFO Assets” has the meaning given such term in Section 6.2(a). 

“ROFO Notice” has the meaning given such term in Section 6.2(a). 

“ROFO Party” has the meaning given such term in Section 6.2(a). 

  
 7 

 “ROFO Response” has the meaning given such term in Section 6.2(a).

 “SC&C” has the meaning given such term in the introduction to this Agreement. 

“Seller” has the meaning given such term in Section 6.2(a). 

“Senior Notes” means the Partnership’s [            ]%
Senior Notes due 2020. 
 “Senior Notes Offering” means the Partnership’s offering, concurrent with the
Initial Public Offering, of $[            ] aggregate principal amount of Senior Notes. 
 “Sponsor” has the meaning given such term in the introduction to this Agreement. 
 “Sponsor Covered Environmental Losses” means, collectively, the Known Remediation Losses and the Unknown Remediation Losses. 

“Sponsor Entities” means the Sponsor and any Affiliate of the Sponsor other than the Partnership Entities; and
“Sponsor Entity” means any of the Sponsor Entities. 
 “Sponsor ROFO Assets” has the meaning
given such term in Section 6.2(a). 
 “Subordinated Units” has the meaning given such term in the
Partnership Agreement. 
 “Subsidiary” means, with respect to any Person, (a) a corporation of which more
than 50% of the voting power of shares entitled (without regard to the occurrence of any contingency) to vote in the election of directors or other governing body of such corporation is owned, directly or indirectly, at the date of determination, by
such Person, by one or more Subsidiaries of such Person or a combination thereof, (b) a partnership (whether general or limited) in which such Person or a Subsidiary of such Person is, at the date of determination, a general partner of such
partnership, but only if such Person, directly or by one or more Subsidiaries of such Person, or a combination thereof, controls such partnership on the date of determination or (c) any other Person in which such Person, one or more
Subsidiaries of such Person, or a combination thereof, directly or indirectly, at the date of determination, has (i) at least a majority ownership interest or (ii) the power to elect or direct the election of a majority of the directors or
other governing body of such Person. 
 “Sun Coal & Coke Contribution” has the meaning given such term
in the Recitals of this Agreement. 
 “SunCoke Name” has the meaning given such term in Section 2.2(b).

 “Transfer” means to, directly or indirectly, sell, assign, lease, convey, transfer or otherwise dispose of,
whether in one or a series of transactions; provided, however, that in no event shall a Change of Control of Sponsor be deemed a Transfer. 
 “Unknown Remediation Losses” means Environmental Losses other than Known Remediation Losses, occurring or existing on or before the Closing Date, whether discovered before or after the
Closing Date, and identified after the Closing Date as requiring remediation. 

  
 8 

 “Voluntary Cleanup Program” means a program of the United States or a
state of the United States enacted pursuant to Environmental Laws that provides for a mechanism for the written approval of, or authorization to conduct, voluntary investigatory and remedial action for the clean-up, removal or remediation of
Hazardous Substances that exceeds actionable levels established pursuant to Environmental Laws. 
 “Voting
Securities” of a Person means securities of any class of such Person entitling the holders thereof to vote in the election of, or to appoint, members of the board of directors or other similar governing body of the Person; provided that, if
such Person is a limited partnership, Voting Securities of such Person shall be the general partner interest in such Person. 

ARTICLE 2 

INTELLECTUAL PROPERTY LICENSE 
 Section 2.1 License Grant. 
 (a) Licensor hereby grants
Licensees, who hereby accept, a royalty-free, fully paid up, nonexclusive and nontransferable right and license to use the Intellectual Property, solely in connection with the Licensed Uses and solely in the United States and Canada. Except for such
license, all other rights in the Intellectual Property are hereby reserved to Licensor. Licensees shall not grant any sublicenses or assign, delegate or otherwise transfer their rights or obligations hereunder or any interest herein (including any
assignment or transfer occurring by operation of law) without the prior written consent of Licensor. 
 Section 2.2
Restrictions and Additional Agreements with Respect to License. 
 (a) Licensor, and its other licensees,
shall have the right to use the Intellectual Property simultaneously with the use of the Intellectual Property by Licensees. Licensor does not warrant or represent that Licensees will have the sole and exclusive right to use the
Intellectual Property. Other than as set forth in Section 2.3(b) and Section 2.4 herein, Licensor is not obliged to indemnify or reimburse Licensees for any expenses by Licensees in connection with Licensees’ use of the
Intellectual Property. 
 (b) Licensees’ license to use the Mark Intellectual Property shall terminate upon
the earlier to occur of (i) in the event of a Change of Control, six months after receipt by the General Partner, on behalf of the Licensees, of written notice of termination from Licensor and (ii) termination of this Agreement. Licensees
shall not thereafter use or otherwise exploit the Mark Intellectual Property and shall not use any name incorporating the “SunCoke” name or any derivation thereof that would reasonably be expected to be confused therewith (the
“SunCoke Name”), or any other trade names, domain name, trade dress, trademark or service mark confusingly similar thereto, and each Licensee shall promptly assign and transfer its rights in any ownership of the trade names
incorporating the SunCoke Name to Licensor and each Licensee shall adopt a new trade name that does not use any SunCoke Name. 
 (c) Licensees’ license to use the Improvements shall terminate upon termination of this Agreement, provided, however that Licensees’ license shall survive

  
 9 

 
any termination with respect to any Improvements (i) that have been materially implemented by Licensees prior to such termination or (ii) with respect to which Licensees have incurred
material implementation expenses prior to such termination (the Improvements described in subclauses (i) and (ii), the “Implemented Improvements”). 

(d) Licensees’ right to use the Non-Mark Intellectual Property and the Implemented Improvements shall be perpetual
and irrevocable and shall survive any termination or expiration of this Agreement and shall remain in full force and effect. 

Section 2.3 Covenants of Licensor and Licensees. 

(a) Licensees shall: 
 (i) upon Licensor’s request and at Licensor’s expense, place a notice (reasonably acceptable to Licensor) in connection with Licensees’ external uses of the Mark Intellectual Property
conveying to the public that the Mark Intellectual Property is owned by Licensor and used by Licensees under license; 
 (ii) upon Licensor’s request and at Licensor’s expense, cooperate with Licensor in facilitating Licensor’s control of the nature and quality of the Licensed Uses, and all materials that
bear the Mark Intellectual Property; 
 (iii) upon Licensor’s request and at Licensor’s expense,
cooperate with Licensor in connection with Licensor’s efforts to protect the Intellectual Property; 
 (iv)
maintain in strictest confidence all confidential or nonpublic information or material disclosed by Licensor and in the materials supplied hereunder in connection with the licenses granted herein, whether in writing or orally and whether or not
marked as confidential, including but not limited to any algorithms, inventions, ideas, processes, computer system architecture and design, operator interfaces, operational systems, technical information, technical specifications, training and
instruction manuals, and the like (except to the extent such information becomes publically available); and 

(v) limit disclosure of such confidential information to Licensees’ Representatives having a need to access the
confidential information for the purpose of exercising rights granted hereunder and cause all of its Representatives having access to confidential information to agree to hold such in the strictest of confidence. 

(b) Licensor shall promptly reimburse Licensees for all costs and expenses incurred by Licensees in connection with
Licensees’ obligations pursuant to Section 2.30(i)-(iii). Licensor’s reimbursement obligation pursuant to this Section 2.3(b) shall survive any termination of this Agreement and shall remain in full force and effect. 

  
 10 

 Section 2.4 Intellectual Property Indemnification. 

(a) Licensees shall defend, indemnify, and hold harmless Licensor from and against any Losses suffered or incurred by
Licensor arising out of any failure by Licensees or their Representatives to maintain confidentiality as required by Section 2.3(a)(iv) and Section 2.3(a)(v) hereof. 

(b) Licensor shall defend, indemnify, and hold harmless Licensees from and against any Losses suffered or incurred by
Licensees arising from (i) claims or causes of action brought by any third party alleging that any Licensee’s use of Intellectual Property, as permitted under this Agreement, violates any law, statute or rule, or infringes, dilutes,
misappropriates or otherwise violates the intellectual property rights of such third party; (ii) invalidity or unenforceability of any right with respect to the Intellectual Property; (iii) premature expiration of Patent Rights; and
(iv) Licensor’s failure to timely file or pay any application, registration, maintenance or renewal fees in respect of the Intellectual Property. 
 (c) The indemnification obligations under this Section 2.4 shall survive any termination of this Agreement and shall remain in full force and effect; provided however that following a termination of
this Agreement, Licensor shall not be obligated to indemnify Licensees for losses related to any Improvements; provided further that Licensor shall, upon Licensees’ request and at Licensees’ expense, take action to protect Licensees’
rights hereunder with respect to Improvements. 
 ARTICLE 3 

INDEMNIFICATION 
 Section 3.1 Sponsor’s Environmental Indemnification Obligations. 
 (a) Subject to Section 3.4, the Sponsor shall indemnify, defend and hold harmless the Partnership Group from and against all Environmental Losses that occurred or existed on or before the Closing
Date as described on Schedule 3.1 (collectively, “Known Remediation Losses”), but only to the extent such Environmental Losses occurred or existed on or before the Closing Date, even if such Environmental Losses do not accrue until
after the Closing Date. 
 (b) Subject to Section 3.1(c) and Section 3.4, the Sponsor shall indemnify,
defend and hold harmless the Partnership Group from and against any Unknown Remediation Losses; 
 (c) Except for
obligations with respect to claims made in accordance with Section 3.5 prior to the fifth anniversary of the Closing Date, which shall not terminate, all indemnification obligations pursuant to Section 3.1(b) shall terminate on the fifth
anniversary of the Closing Date. 
 Section 3.2 Partnership Group’s Indemnification Obligations. The Partnership Group
shall indemnify, defend and hold harmless the Sponsor Entities from and against any Environmental Losses suffered or incurred by the Sponsor Entities relating to the ownership or 

  
 11 

 
operation of the Partnership Assets to the extent occurring after the Closing Date (“Partnership Covered Environmental Losses”), except to the extent that the Partnership Group
is indemnified with respect to any of such Environmental Losses that are Sponsor Covered Environmental Losses under Sections 3.1 (a) and 3.1(b). 
 Section 3.3 Additional Indemnification. In addition to and not in limitation of the indemnification provided under Section 3.1(a) and Section 3.1(b), Sponsor shall either cure, as
applicable, or fully indemnify, defend and hold harmless the Partnership Group from and against any and all: 

(a) tax liabilities arising prior to the Closing Date or in connection with the closing of the Initial Public Offering;
and 
 (b) Losses of any and every kind or character, known or unknown, fixed or contingent, suffered or incurred
by the Partnership Group by reason of or arising out of any: 
 (i) failure of the Partnership Group to be the
owner on the Closing Date of (x) valid and indefeasible title to the Partnership Assets, (y) valid and indefeasible easement rights, rights-of-way, leasehold and/or fee ownership interests in and to the lands on which are located any
Partnership Assets and (z) valid title to the equity interests in Haverhill and Middletown contributed to the Partnership by SC&C as part of the Sun Coal & Coke Contribution, in each case to the extent that such failure renders the
Partnership Group liable or unable to use or operate the Partnership Assets in substantially the same manner as they were operated immediately prior to the Closing Date; 

(ii) failure of the Partnership Group to have on the Closing Date any consent or governmental permit to the extent that
such failure renders the Partnership unable to use or operate the Partnership Assets in substantially the same manner as they were operated immediately prior to the Closing Date; or 

(iii) events or conditions associated with the Retained Assets whether occurring before or after the Closing Date.

 Section 3.4 Limitations Regarding Indemnification. 

(a) No claims may be made against the Sponsor for indemnification pursuant to (i) Section 3.1(a) unless and
until the aggregate dollar amount of the Known Remediation Losses suffered or incurred by the Partnership Group exceeds $[            ] million, and the Sponsor shall have no liability in
respect of the first $ [            ] million of Known Remediation Losses and (ii) Section 3.1(b) unless and until the aggregate dollar amount of the Unknown Remediation Losses
suffered or incurred by the Partnership Group exceeds $[5] million, and the Sponsor shall have no liability in respect of this first $[5] million of Unknown Remediation Losses. 
 (b) The aggregate liability of the Sponsor under Section 3.1(b) shall not exceed $[50] million. 

  
 12 

 (c) Notwithstanding anything herein to the contrary, in no event shall the
Sponsor Entities have any indemnification obligations under Section 3.1(a) or Section 3.1(b) for Losses that arise solely as a result of additions to or modifications of Environmental Laws promulgated after the Closing Date. 

Section 3.5 Indemnification Procedures. 

(a) The Indemnified Party agrees that within a reasonable period of time after it becomes aware of facts giving rise to a
claim for indemnification under this Article 3, it will provide notice thereof in writing to the Indemnifying Party, specifying the nature of and specific basis for such claim; provided, that failure to timely provide such notice shall not affect
the right of the Indemnified Party’s indemnification hereunder, except in the event and only to the extent the Indemnifying Party is materially prejudiced by such delay or omission. 

(b) The Indemnifying Party shall have the right to control all aspects of the defense of (and any counterclaims with
respect to) any claims brought against the Indemnified Party that are covered by the indemnification under this Article 3, including, without limitation, the selection of counsel, determination of whether to appeal any decision of any court and the
settling of any such matter or any issues relating thereto; provided, however, that no such settlement shall be entered into without the consent of the Indemnified Party (with the concurrence of the Conflicts Committee in the case of the Partnership
Group) unless it includes a full release of the Indemnified Party from such matter or issues, as the case may be, and does not include the admission of fault, culpability or a failure to act, by or on behalf of such Indemnified Party. 

(c) The Indemnified Party agrees to cooperate fully with the Indemnifying Party, with respect to all aspects of the
defense of any claims covered by the indemnification under this Article 3, including, without limitation, the prompt furnishing to the Indemnifying Party of any correspondence or other notice relating thereto that the Indemnified Party may receive,
permitting the name of the Indemnified Party to be utilized in connection with such defense, the making available to the Indemnifying Party of any files, records or other information of the Indemnified Party that the Indemnifying Party reasonably
considers relevant to such defense and the making available to the Indemnifying Party, at no cost to the Indemnifying Party, of any directors, officers or employees of the Indemnified Party; provided, however, that in connection therewith the
Indemnifying Party agrees to use reasonable efforts to minimize the impact thereof on the operations of the Indemnified Party and further agrees to endeavor to maintain the confidentiality of all files, records and other information furnished by the
Indemnified Party pursuant to this Section 3.5. In no event shall the obligation of the Indemnified Party to cooperate with the Indemnifying Party as set forth in the immediately preceding sentence be construed as imposing upon the Indemnified
Party an obligation to hire and pay for counsel in connection with the defense of any claims covered by the indemnification set forth in this Article 3; provided, however, that the Indemnified Party may, at its own option, cost and expense, hire and
pay for counsel in connection with any such defense. The Indemnifying Party agrees to keep any such counsel hired by the 

  
 13 

 
Indemnified Party reasonably informed as to the status of any such defense, but the Indemnifying Party shall have the right to retain sole control over such defense. 

(d) An Indemnified Party shall take all commercially reasonable steps to mitigate damages with respect to any claim for
which it is seeking indemnification and shall use commercially reasonable efforts to avoid any costs or expenses associated with such claim and, if such costs and expenses cannot be avoided, to minimize the amount thereof. 

(e) In determining the amount of any Losses for which the Indemnified Party is entitled to indemnification under this
Agreement, the gross amount of the indemnification will be reduced by (i) any insurance proceeds realized by the Indemnified Party, and such correlative insurance benefit shall be net of any incremental insurance premium that becomes due and
payable by the Indemnified Party as a result of such claim and (ii) all amounts recovered by the Indemnified Party under contractual indemnities from third parties. The Indemnified Party hereby agrees to use reasonable efforts to realize any
applicable insurance proceeds or amounts recoverable under such contractual indemnities, provided, however, that the costs and expenses of the Indemnified Party in connection with such efforts shall be promptly reimbursed by the Indemnifying Party.

 (f) The date on which the Indemnifying Party receives notification of a claim in accordance with
Section 3.5(a) for indemnification shall determine whether such claim is timely made. 
 (g) NOTWITHSTANDING
ANYTHING HEREIN TO THE CONTRARY, IN NO EVENT SHALL ANY PARTY’S INDEMNIFICATION OBLIGATION HEREUNDER COVER OR INCLUDE CONSEQUENTIAL, INDIRECT, INCIDENTAL, PUNITIVE, EXEMPLARY, SPECIAL OR SIMILAR DAMAGES OR LOST PROFITS SUFFERED BY ANY OTHER
PARTY ENTITLED TO INDEMNIFICATION UNDER THIS AGREEMENT. 
 Section 3.6 In the Event of Termination. Except as provided by
Section 3.1(c), all indemnification obligations under this Article 3 shall survive any termination of this Agreement, and shall remain in full force and effect. 
 ARTICLE 4 
 AGREEMENT WITH RESPECT TO CUSTOMER CONTRACTS 

Section 4.1 Assumption of Customer Obligations by Sponsor. 

(a) If AK Steel exercises its early termination right under Section 11.6 of the AK Steel Coke Agreement, then upon
receipt of written notice from the Partnership of effectiveness of such termination, the Sponsor will be obligated to make the Partnership Group whole to the extent of the AK Steel Obligations for the remainder of the term of the AK Steel Coke
Agreement, either by purchasing and paying for coke or otherwise, pursuant to an agreement the terms of which are reasonably acceptable to the Partnership. 

  
 14 

 (b) If, other than as a result of the exercise of the termination right
described in Section 4.1(a), a Force Majeure Event (as defined in the relevant Coke Sales Agreement) or a Seller Event of Default (as defined in the relevant Coke Sales Agreement), (i) a customer fails to fully satisfy its purchase and
payment obligations pursuant to the terms of a Coke Sales Agreement to which such customer is a party, or (ii) a Coke Sales Agreement is amended to reduce a customer’s purchase or payment obligations as a result of the customer’s
financial distress, whether or not the customer or an affiliate of the customer has filed a petition in bankruptcy, then upon written notice from the Partnership, the Sponsor will be obligated to make the Partnership Group whole to the extent of the
customer’s failure to satisfy its obligations or to the extent the customer’s obligations are reduced, as applicable, either by purchasing and paying for coke or otherwise, pursuant to an agreement the terms of which are reasonably
acceptable to the Partnership (but, for the avoidance of doubt, without relieving such customer of its coke purchase obligations under the relevant Coke Sales Agreement). 

(c) Notwithstanding any provision of this agreement to the contrary, the Sponsor’s obligations pursuant to
Section 4.1(a) and (b), will be determined based on the customer’s obligations under the relevant Coke Sales Agreement as in effect on the Closing Date. Further, for the avoidance of doubt, the Partnership Group’s obligation to
produce coke under such Coke Sales Agreement will not exceed the supply obligation required under such Coke Sales Agreement as of the Closing Date. 
 (d) In the case of any amendment to a Coke Sales Agreement referred to in Section 4.1(b)(ii), the Partnership will use its reasonable commercial efforts to structure the amendment to minimize the
Sponsor’s payment obligations pursuant to this Section 4.1. 
 Section 4.2 Allocation of Amounts Recovered under
Coke Sales Agreements. 
 (a) The Partnership, on behalf of the Partnership Group, and the Sponsor, on behalf
of the Sponsor Entities, will share in any damages and other amounts recovered from third parties in connection with the occurrence of any of the events described in Section 4.1(a) or Section 4.1(b) (including any damages, settlements,
insurance proceeds, termination fees and amounts recovered pursuant to contractual indemnities) in such proportion as is appropriate to reflect the relative loss and/or prospective loss suffered by the Partnership Group, on the one hand, and the
Sponsor Entities, on the other. 
 (b) The Partnership and the Sponsor shall each use its reasonable commercial
efforts to pursue damages and/or recover amounts payable by customers or other third parties as a result of any of the events described in Section 4.1(a) or Section 4.1(b), and any related costs and expenses will be shared by the
Partnership and the Sponsor in the same proportion as would apply to amounts collected pursuant to Section 4.2(a). 

Section 4.3 Term of Agreement with Respect to Customer Contracts. The Sponsor’s obligations pursuant to this Article 4, as
well as any obligations assumed by the Sponsor hereunder, shall terminate on the fifth anniversary of the Closing Date. 

  
 15 

 ARTICLE 5 
 BUSINESS OPPORTUNITIES 
 Section 5.1 Preferential Rights.

 (a) Except as permitted by Section 5.2, the Sponsor Entities shall be prohibited from investing in,
constructing, or acquiring an interest in any Domestic Cokemaking Asset. 
 (b) The Partnership Entities shall be
prohibited from pursuing any business opportunity other than investments in, construction of, or acquisitions of Domestic Cokemaking Assets, except upon the written consent of the Sponsor, which consent shall be given or withheld at the sole
discretion of the Sponsor and which shall be limited by such conditions as Sponsor may require at its sole discretion. 

Section 5.2 Permitted Exceptions. The Sponsor Entities may engage in the following activities under the following circumstances:

 (a) Any investment in, construction of, or acquisition of assets or an interest in any assets or business
other than Domestic Cokemaking Assets. 
 (b) Subject to Section 5.3, any investment in, construction of, or
acquisition of an interest in any Domestic Cokemaking Asset if: 
 (i) in accordance with the procedures set
forth in Section 5.3(a), the Sponsor Entities have offered the Partnership the opportunity to pursue such investment, construction or acquisition opportunity and the Partnership has elected in writing not to pursue such opportunity; or

 (ii) the Sponsor Entities, as of the Closing Date, are actively pursuing such an opportunity, including
without limitation the Kentucky Facility. 
 Section 5.3 Business Opportunities Procedures. 

(a) As contemplated by Section 5.2(b)(i), in the event that the Sponsor or any other Sponsor Entity becomes aware of
an opportunity to invest in, construct or acquire an interest in a Domestic Cokemaking Asset, then as soon as practicable, the Sponsor or other Sponsor Entity shall notify the General Partner in writing of such opportunity and deliver to the General
Partner, or provide the General Partner access to, all information prepared by or on behalf of, or material information submitted or delivered to, the Sponsor or such Sponsor Entity related to such potential transaction. As soon as practicable, but
in any event within 30 days after receipt of such notification and information, the General Partner, on behalf of the Partnership, having determined whether to pursue such opportunity in consultation with the Conflicts Committee, shall give notice
in writing (the “Business Opportunity Notice”) to the Sponsor or other Sponsor Entity that either (i) the General Partner, on behalf of the Partnership, has elected not to cause the Partnership Group to pursue such investment,
acquisition or construction opportunity, or (ii) the General Partner, on behalf of the Partnership, has elected to cause 

  
 16 

 
the Partnership Group to pursue such investment, acquisition or construction opportunity. If no Business Opportunity Notice is delivered by the General Partner within the 30-day period, then the
General Partner, on behalf of the Partnership shall be deemed to have elected not to pursue such opportunity. If, after delivering a Business Opportunity Notice electing to pursue an opportunity, the General Partner abandons such opportunity (as
evidenced in writing by the General Partner following the written request of the Sponsor) or fails to endeavor in good faith to pursue such opportunity, the Sponsor or any other Sponsor Entity may pursue the opportunity. With respect to any
opportunity to invest in, acquire or construct Domestic Cokemaking Assets that the Sponsor Entities pursue, (x) the Sponsor Entities must endeavor in good faith to pursue the opportunity and (y) any such investment, construction or
acquisition must be on terms not materially more favorable to the Sponsor Entities than were offered to the Partnership. If at any time either of the conditions set forth in subclauses (x) and (y) are not satisfied, the opportunity must be
reoffered to the Partnership in accordance with this Section 5.3(a). For the avoidance of doubt, any Domestic Cokemaking Asset acquired by the Sponsor Entities in accordance with this Section 5.3(a) will be subject to the Right of First
Offer pursuant to Article 6. 
 (b) In the event that any of the Sponsor Entities constructs a new cokemaking
facility in the United States or Canada pursuant to the exception provided in Section 5.2(b) in compliance with the procedures set forth in Section 5.3(a), then upon commencement of commercial operations, the Partnership shall have the
option to acquire or to cause another Group Member to acquire such facility at a price sufficient to provide the Sponsor with an internal rate of return on invested capital equal to the sum of the Sponsor Entities’ weighted average cost of
capital (as determined in good faith by the Sponsor) and [6.0]%. The Sponsor shall promptly provide the General Partner with, or provide the General Partner access to, all information related to such cokemaking facility as the General Partner
reasonably requests. The Sponsor shall promptly provide written notice (the “Commercial Operations Notice”) to the General Partner upon commencement of commercial operations at the newly constructed cokemaking facility. Within 90
days of receipt of a Commercial Operations Notice, the General Partner, following consultation with the Conflicts Committee, shall notify the Sponsor in writing as to whether or not it will exercise its option to acquire such facility. For the
avoidance of doubt, (i) if the Sponsor Entities construct the Kentucky Facility, the Partnership’s option to purchase newly constructed cokemaking facilities set forth in this Section 5.3(b) shall apply to the Kentucky Facility, and
(ii) if the Partnership Group does not exercise the option outlined in this Section 5.3(b) to acquire any particular newly constructed cokemaking facility upon commencement of commercial operations (including the Kentucky Facility), such
cokemaking facility will be subject to the Right of First Offer pursuant to Article 6. 

  
 17 

 ARTICLE 6 
 RIGHT OF FIRST OFFER 
 Section 6.1 Right of First Offer to Purchase
Certain Assets. 
 (a) The Sponsor hereby grants to the Partnership a right of first offer on any Domestic
Cokemaking Asset to the extent that any Sponsor Entity proposes to Transfer any such Domestic Cokemaking Asset, or any interest therein (other than to another wholly owned Sponsor Entity). 

(b) The Partnership hereby grants to the Sponsor a right of first offer on any cokemaking facility or interest therein or
interest in any business engaged in cokemaking, to the extent that any Group Member proposes to Transfer any such asset or interest (other than to another wholly owned Group Member). 

(c) The Parties acknowledge that any Transfer of assets or interests pursuant to the Partnership’s or Sponsor’s
right of first offer is subject to the terms of all existing agreements with respect to such assets and interests and shall be subject to and conditioned on the obtaining of any and all necessary consents of security holders, governmental
authorities, lenders or other third parties. 
 Section 6.2 Procedures. 

(a) If a Sponsor Entity or a Group Member (the “Seller”) proposes to Transfer, in the case of a Sponsor
Entity, any Domestic Cokemaking Asset or an interest therein (the “Sponsor ROFO Assets”) or in the case of a Partnership Party, any cokemaking facility or interest therein or interest in any business engaged in cokemaking (the
“Partnership ROFO Assets”, and together with the Sponsor ROFO Assets, the “ROFO Assets”) other than to, in the case of a Sponsor Entity, another Sponsor Entity as described in Section 6.1(a) or, in the case of
a Group Member, another Group Member as described in Section 6.1(b) (a “Proposed Transaction”), the Sponsor, in the case of a proposed Transfer by any Sponsor Entity, or the General Partner, in the case of a proposed Transfer
by any Group Member, shall, prior to entering into any such Proposed Transaction, first give notice in writing (the “ROFO Notice”) to the other party (the “ROFO Party”) of its intention to enter into such Proposed
Transaction. The ROFO Notice shall include any material terms, conditions and other details as would be reasonably necessary for the ROFO Party to make a responsive offer to enter into the Proposed Transaction with the Seller, which terms,
conditions and details shall include any material terms, conditions or other details that the Seller would propose to provide to non-Affiliates in connection with the Proposed Transaction. The ROFO Party shall have 30 days following receipt of the
ROFO Notice to propose an offer to enter into the Proposed Transaction with the Seller (the “ROFO Response”). The ROFO Response shall set forth the terms and conditions (including, without limitation, the purchase price the ROFO
Party proposes to pay for the ROFO Asset and the other material terms of the purchase) pursuant to which the ROFO Party would be willing to enter into a binding agreement for the Proposed Transaction. If no ROFO Response is delivered by the ROFO
Party within such 30 day period, then the ROFO Party shall be deemed to have waived its 

  
 18 

 
right of first offer with respect to such ROFO Asset, and the Seller shall be free to enter into a Proposed Transaction with any third party on terms and conditions determined in the sole
discretion of the Seller. If the Seller fails to complete such a transaction within 270 days of the last day of the aforementioned 30-day period, then any future Transfer of such ROFO Asset by the Seller will be subject to the provisions of this
Article 6 in full. 
 (b) If the ROFO Party submits a ROFO Response, the ROFO Party and the Seller shall
negotiate, in good faith, the terms of the purchase and sale of the ROFO Asset for 30 days following the Seller’s receipt of the ROFO Response. If the Seller and the ROFO Party are unable to agree on such terms during such 30-day period, the
Seller may Transfer the ROFO Asset to any third party on terms not materially more favorable to the Seller than the last written offer proposed during negotiations with the ROFO Party pursuant to this Section 6.2(b). If the Seller fails to
complete such a transaction within 270 days of the last day of the aforementioned 30-day negotiation period, then any future Transfer of such ROFO Asset by the Seller will be subject to the provisions of this Article 6 in full. 

ARTICLE 7 

EXPENSES AND REIMBURSEMENT OBLIGATIONS 
 Section 7.1 Provision of General and Administrative Services. The Sponsor hereby agrees to continue to provide, or cause to be provided, the Partnership Entities with general and administrative
services that the Sponsor has traditionally provided in connection with the Partnership Assets, including, without limitation, executive management, human resources, financial (including, but not limited to, tax, accounting and audit services),
legal, information technology, communications, engineering, insurance (including insurance administration, claims processing and coverage under the Sponsor’s policies), risk management, credit, payroll, compensation and employee benefits
services, that are substantially identical in nature and quality to the services provided by the Sponsor in connection with its management and operations of the Partnership Assets prior to the Closing date. 

Section 7.2 Reimbursement and Allocation. The Partnership hereby agrees to reimburse the Sponsor Entities for (i) all direct
costs and expenses incurred and payments made by the Sponsor Entities on behalf of the Partnership Entities and (ii) costs and expenses incurred by Sponsor Entities that are allocated to the Partnership Entities in accordance with Schedule 7.2
(as may be modified from time to time in accordance with Section 8.6), including but not limited to: 
 (a)
salaries of employees of the Sponsor Entities; 
 (b) the cost of employee benefits relating to employees of the
Sponsor Entities, including 401(k), pension, bonuses and health insurance benefits (but excluding Sponsor equity based compensation expense); 
 (c) any expenses incurred or payments made by the Sponsor Entities for insurance coverage with respect to the Partnership Assets or the business of the Partnership Entities; 

  
 19 

 (d) all expenses and expenditures incurred by the Sponsor Entities as a
result of the Partnership becoming and continuing as a publicly traded entity, including, but not limited to, costs associated with annual and quarterly reports, tax return and Schedule K-1 preparation and distribution expenses, partnership
governance and compliance fees and expenses, expenses associated with listing on the New York Stock Exchange or any other national exchange on which the Partnership’s securities are listed, independent auditor fees, legal fees, investor
relations expenses, registrar and transfer agent fees, director and officer insurance expenses and director compensation expenses; 
 (e) all sales, use, excise, value added or similar taxes, if any, that may be applicable from time to time with respect to the services provided by the Sponsor Entities to the Partnership Entities in
accordance with Section 7.1. 
 Such reimbursements shall be made on or before the tenth business day of the month
following the month such costs and expenses are incurred, other than reimbursements solely related to bonuses for employees, which shall be reimbursed on or prior to the last business day of the month that such bonuses are paid. 

Section 7.3 Debt Financing Fees. The Partnership shall pay (i) all fees, commissions and issuance costs in connection with
the Senior Notes Offering, including amounts due at or in connection with the closing of the Senior Notes Offering and all ongoing fees (ii) all fees due under or in connection with the MLP Credit Agreement, including amounts due upon or in
connection with execution of the MLP Credit Agreement and all ongoing fees, and (iii) all fees, commissions and issuance costs due in connection with any future debt financing arrangements entered into for the purpose of replacing the MLP
Credit Agreement or the Senior Notes. 
 ARTICLE 8 
 MISCELLANEOUS 
 Section 8.1 Choice of Law; Submission to
Jurisdiction. This Agreement shall be subject to and governed by the laws of the State of New York, excluding any conflicts-of-law rule or principle that might refer the construction or interpretation of this Agreement to the laws of another
state. Each Party hereby submits to the jurisdiction of the state and federal courts in the State of New York and to venue in New York, New York. 
 Section 8.2 Notice. All notices, requests or consents provided for or permitted to be given pursuant to this Agreement must be in writing and must be given by depositing same in the United States
mail, addressed to the Person to be notified, postpaid, and registered or certified with return receipt requested or by delivering such notice in person or by overnight courier, telecopier or telegram to such Party. Notice given by personal delivery
or mail shall be effective upon actual receipt. Notice given by overnight courier, telegram or telecopier shall be effective upon actual receipt. All notices to be sent to a Party pursuant to this Agreement shall be sent to or made at the address
set forth below or at such other address as such Party may stipulate to the other Parties in the manner provided in this Section 8.2. 

  
 20 

 For notices to any of the Sponsor Entities: 

SunCoke Energy, Inc. 
 1011 Warrenville Road, Suite 600 
 Lisle, Illinois 60532

 Fax: (630) 824-1004 

Attention: General Counsel 
 For notices to any of the Partnership Entities: 
 SunCoke
Energy Partners, L.P. 
 1011 Warrenville Road, Suite 600 

Lisle, Illinois 60532 
 Fax: (630) 824-1004 
 Attention: General Counsel 

Section 8.3 Entire Agreement. This Agreement constitutes the entire agreement of the Parties relating to the matters contained
herein, superseding all prior contracts or agreements, whether oral or written, relating to the matters contained herein, other than the Contribution Agreement and the Partnership Agreement. 

Section 8.4 Termination. Except as provided in Section 2.2(b), Section 2.2(c), Section 2.2(d), Section 2.3(b),
Section 2.4(c), Section 3.1(c), Section 3.6 and Section 4.3, this Agreement shall terminate upon a Change of Control of the General Partner or the Partnership, other than any Change of Control of the General Partner or the
Partnership deemed to have occurred pursuant to clause (d) of the definition of Change of Control solely as a result of a Change of Control of the Sponsor. Notwithstanding any other provision of this Agreement, except as provided in
Section 2.2(b), Section 2.2(c), Section 2.2(d), Section 2.3(b), Section 2.4(c), Section 3.1(c), Section 3.6 and Section 4.3, if the General Partner is removed as general partner of the Partnership under
circumstances where Cause does not exist and the Common Units held by the General Partner and its Affiliates are not voted in favor of such removal, this Agreement may immediately thereupon be terminated by the Sponsor. 

Section 8.5 Effect of Waiver or Consent. No waiver or consent, express or implied, by any Party to or of any breach or default by
any Person in the performance by such Person of its obligations hereunder shall be deemed or construed to be a consent or waiver to or of any other breach or default in the performance by such Person of the same or any other obligations of such
Person hereunder. Failure on the part of a Party to complain of any act of any Person or to declare any Person in default, irrespective of how long such failure continues, shall not constitute a waiver by such Party of its rights hereunder until the
applicable statute of limitations period has run. 
 Section 8.6 Amendment or Modification. This Agreement may be amended
or modified from time to time only by the written agreement of all the Parties; provided, however, that the Partnership may not, without the prior approval of the Conflicts Committee, agree to any amendment or modification of this Agreement that
will adversely affect the holders of Common Units. Each such instrument shall be reduced to writing and shall be designated on its face an 

  
 21 

 
“Amendment” or an “Addendum” to this Agreement. Notwithstanding the first sentence of this Section 8.6, Schedule 7.2 may be amended or modified from time to time only by
the written agreement of the Partnership and the Sponsor. 
 Section 8.7 Assignment; Third Party Beneficiaries. Except as
set forth in Section 2.1(a), any Party shall have the right to assign its rights under this Agreement without the consent of any other Party, but no Party shall have the right to assign its obligations under this Agreement without the written
consent of the other Parties. Each of the Parties hereto specifically intends that each entity comprising the Sponsor Entities and each entity comprising the Partnership Entities, as applicable, whether or not a Party to this Agreement, shall be
entitled to assert rights and remedies hereunder as third-party beneficiaries hereto with respect to those provisions of this Agreement affording a right, benefit or privilege to any such entity, and that no other Person shall be entitled to assert
any rights or remedies hereunder as third-party beneficiaries. 
 Section 8.8 Counterparts. This Agreement may be
executed in two or more counterparts, and by facsimile, each of which shall be deemed to be an original, but all of which shall constitute one and the same agreement. 
 Section 8.9 Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any applicable rule of law or public policy, all other conditions
and provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any Party. Upon such
determination that any term or other provision is invalid, illegal or incapable of being enforced, the Parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible in
an acceptable manner to the end that transactions contemplated hereby are fulfilled to the extent possible. 
 Section 8.10
Gender, Parts, Articles and Sections. Whenever the context requires, the gender of all words used in this Agreement shall include the masculine, feminine and neuter, and the number of all words shall include the singular and plural. All
references to Article numbers and Section numbers refer to Articles and Sections of this Agreement. 
 Section 8.11 Further
Assurances. In connection with this Agreement and all transactions contemplated by this Agreement, each Party agrees to execute and deliver such additional documents and instruments and to perform such additional acts as may be necessary or
appropriate to effectuate, carry out and perform all of the terms, provisions and conditions of this Agreement and all such transactions. 
 Section 8.12 Withholding or Granting of Consent. Except as otherwise expressly provided in this Agreement, each Party may, with respect to any consent or approval that it is entitled to grant
pursuant to this Agreement, grant or withhold such consent or approval in its sole and uncontrolled discretion, with or without cause, and subject to such conditions as it shall deem appropriate. 

  
 22 

 Section 8.13 Laws and Regulations. Notwithstanding any provision of this Agreement
to the contrary, no Party shall be required to take any act, or fail to take any act, under this Agreement if the effect thereof would be to cause such Party to be in violation of any applicable law, statute, rule or regulation. 

Section 8.14 Negation of Rights of Limited Partners, Assignees and Third Parties. Except as set forth in Section 8.7,
the provisions of this Agreement are enforceable solely by the Parties, and no shareholder, limited partner, general partner, member, or assignee of the Sponsor, the General Partner, the Partnership or other Person shall have the right, separate and
apart from the Sponsor, the General Partner or the Partnership, to enforce any provision of this Agreement or to compel any Party to comply with the terms of this Agreement. 
 Section 8.15 No Recourse Against Officers and Directors. For the avoidance of doubt, the provisions of this Agreement shall not give rise to any right of recourse against any officer or director of
any Sponsor Entity or any Group Member. 
 Section 8.16 Arbitration. Any dispute, controversy or claim arising out of or
in connection with this Agreement shall be settled by final and binding arbitration conducted in Chicago, Illinois in accordance with the Commercial Arbitration Rules of the American Arbitration Association by one or more arbitrators designated in
accordance with said Rules. The Parties agree that the award of the arbitral tribunal (the “Arbitration Award”) shall be: (a) conclusive, final and binding upon the Parties; and (b) the sole and exclusive remedy between
the Parties regarding any and all claims and counterclaims presented to the arbitral tribunal. All notices to be given in connection with the arbitration shall be as provided in Section 8.2. The Arbitration Award shall include interest, at a
rate determined as appropriate by the arbitrators, from the date of any breach or other violation of this Agreement to the date when the Arbitration Award is paid in full. The Arbitration Award shall also include the fixing of the expense of the
arbitration and the assessment of the same, as is appropriate in the opinion of the arbitrators, against either or both Parties hereto. Each Party shall otherwise bear its cost for its respective legal fees, witnesses, depositions and other
out-of-pocket expenses incurred in the course of the arbitration. 
 Section 8.17 Dispute Resolution. If the Parties are
unable to resolve any service or performance issues or if there is a material breach of this Agreement that has not been corrected within thirty (30) days of receipt of notice of such breach, representatives of each of the Parties in dispute
shall meet promptly to review and resolve such issues and breaches in good faith (the date on which such Persons first so meet, the “Discussion Date”). If such Persons are unable to fully resolve any such issues and breaches in good
faith promptly after the Discussion Date, any remaining disputes shall be resolved in accordance with Section 8.16. 

[Signature pages follow.] 

  
 23 

 IN WITNESS WHEREOF, the Parties have executed this Agreement on, and effective as of, the
Effective Date. 
  

					
	SUNCOKE ENERGY PARTNERS, L.P.
		
	 By:
	 	 SunCoke Energy Partners GP LLC, its general partner

			
		 	 By:
	 	 
		 		 	 Name:

		 		 	 Title:

	
	 SUNCOKE ENERGY PARTNERS GP LLC 

		
	 By:
	 	 
		 	Name:
		 	Title:
	
	 SUNCOKE ENERGY, INC. 

		
	 By:
	 	 
		 	Name:
		 	Title:

 Schedule 2(a) 

Mark Intellectual Property 

 Schedule 2(b) 

Patent Rights 

 Schedule 3.1 
 Known Remediation Losses 

 Schedule 4.2 
 Coke Sales Agreements 

 Schedule 7.2 
 Allocation of Overhead Costs and Expenses

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00210-of-00352.parquet"}]]